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MATHEMATICAL MODELS OF GENE EXPRESSION
PHILIPPE ROBERT
Abstract. In this paper we analyze the equilibrium properties of a large class of
stochastic processes describing the fundamental biological process within bacterial
cells, the production process of proteins. Stochastic models classically used in this
context to describe the time evolution of the numbers of mRNAs and proteins are
presented and discussed. An extension of these models, which includes elongation
phases of mRNAs and proteins, is introduced. A convergence result to equilibrium
for the process associated to the number of proteins and mRNAs is proved and a
representation of this equilibrium as a functional of a Poisson process in an ex-
tended state space is obtained. Explicit expressions for the first two moments of
the number of mRNAs and proteins at equilibrium are derived, generalizing some
classical formulas. Approximations used in the biological literature for the equi-
librium distribution of the number of proteins are discussed and investigated in
the light of these results. Several convergence results for the distribution of the
number of proteins at equilibrium are in particular obtained under different scaling
assumptions.
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2 PHILIPPE ROBERT
1. Introduction
The gene expression is the process by which the genetic information is synthesized
into a functional product, the proteins. These macro-molecules are the crucial agents of
functional properties of cells. They play an important role in most of the basic biological
processes within the cell, either directly, or as a component of complex macro-molecules
such as polymerases or ribosomes. The information flow from DNA genes to proteins is a
fundamental process, common to all living organisms.
We analyze this fundamental process in the context of prokaryotic cells, like bacterial
cells or archaeal cells. The cytoplasm of these cells is not as structured as eukaryotic cells,
like mammalian cells for example, so that most of the macro-molecules of these cells can
potentially collide with each other, including DNA. This key biological process can be,
roughly, described as resulting of multiple encounters/collisions of several types of macro-
molecules of the cell: polymerases with DNA, ribosomes with mRNAs, or proteins with
DNA, . . . An additional feature of this process is that it is consuming an important fraction
of energy resources of the cell, to build chains of amino-acids or chains of nucleotides in
particular.
The fact that the cytoplasm of a bacterial cell is a disorganized medium has important
implications on the internal dynamics of these organisms. Numerous events are triggered
by random events associated to thermal noise. When the external conditions are favorable,
these cells can nevertheless multiply via division at a steady pace. In each cell, around 4000
different types of proteins are produced, with different concentrations: from 5 elements
per cell for some rare proteins to 100,000 per cell for some ribosomal proteins. Despite
of the noisy environment, the protein production process can handle such exponential
growth with these constraints. The cost of the translation phase, the last step of the
protein production process, is estimated to account for 50% of the energy consumption of
a rapidly growing bacterial cell, see Russell and Cook [28] for example.
The key question in this context is of understanding and quantifying the role of the pa-
rameters of the cell in the production of proteins in the context of significant fluctuations.
The high level of energy consumed by protein production suggests that these stochastic
fluctuations are minimized or at least “controlled”, to avoid a shortage of resources, so that
the cell can continue to grow. From the point of view of the design, the cell can be seen as
a system where the processing power is expressed in terms of numerous chemical reactions
occurring in a noisy environment. An important difference with classical, non-biological,
systems, like computer networks, is that there is nowhere the possibility of explicitly stor-
ing information which could be used to regulate the production process. Furthermore,
strictly speaking, there are no functional units processing some kind of “information”.
This is a really challenging aspect of these biological systems.
1.1. The Protein Production Process. We give a quick, simplified, sketch of the steps
involved in the production of proteins. See Watson et al. [35] for a much more detailed
description of these complex processes.
— Gene Activation/Deactivation.
A gene is a contiguous section of the DNA associated to a functional property of
the cell. When a gene is active, a macro-molecule of the cell, an RNA polymerase,
one of the macro-molecules moving in the cytoplasm, can possibly bind to the
DNA at the promoter, i.e. the beginning of the section of DNA for the gene. The
binding to the gene is subject to the various (random) fluctuations of the medium.
The gene may also be inactive and in this case no binding is possible. The reason
is that some macro-molecules, like proteins or mRNAs, of the cell can “block”,
via chemical bonds, the gene so that polymerases cannot access it. This is one of
the regulation mechanisms of the cell. When random perturbations break these
bindings, the gene becomes again active.
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— Transcription. When an RNA polymerase is bound to an active gene, it starts
to make a copy of this gene. The product which is a sequence of nucleotides
is a messenger RNA, or mRNA. The time during which nucleotides are added
sequentially is the elongation phase of the production of the mRNA. When the
full sequence of nucleotides of the mRNA has been successively assembled, the
mRNA is released in the cytoplasm. It has a finite life time, being degraded by
other macro-molecules.
— Translation. The step is achieved through another large macro-molecule: the
ribosome. A ribosome is also moving within the cytoplasm. When it encounters
an mRNA, it can also bind to it via chemical reactions. In this case it builds
a chain of amino-acids, a chain of amino-acids, using the mRNA as a template,
producing a protein. This is the elongation phase of the production of the protein.
As for mRNAs, proteins have also a finite life time. See Figure 1.
Active Gene
Polymerase
Inactive Gene
Ribosome
mRNA
Protein
Figure 1. A Simplified View of the Protein Production Process
1.2. Mathematical Models.
The above description of the protein production process is clearly simplified. The
processes associated to actions of polymerases and ribosomes are composed of several
steps. The way ribosomes bind to mRNAs in particular, see Chapter 14 of Watson et
al. [35] for example. Once a polymerase binds to the gene, the messenger RNA chain
is built through a series of specific stages, in which the polymerase recruits one of the
four nucleotides in accordance to the DNA template. Additionally, a dedicated proof
reading mechanism takes place during this process. There is a similar description for the
translation step. The binding events of polymerases to gene or of ribosomes to mRNAs
are also due to a sequence of specific steps.
Because of the disorganized medium of the bacteria, the protein production process is
a highly stochastic process. The randomness is partially due to the thermal excitation of
the environment. It drives the diffusion of the main components, mRNAs and ribosomes
within the cytoplasm and it also impacts the pairing of cellular components diffusing
through the cytoplasm. It can cause the spontaneous rupture of such pairs, before either
transcription or translation can start.
The problem is of understanding the mechanisms used by the cell to produce a large
number of proteins with very different concentrations in a such a random, “noisy”, context.
The main goals of a mathematical analysis in the biological literature are generally the
following.
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(1) Estimate impact on variance of the number of proteins of assumptions on
— Activation/Deactivation rates of the gene;
— Transcription/Translation rates. Polymerases may bind more easily to some
genes. A similar phenomenon holds for ribosomes and mRNAs. This is
generally mathematically represented via a “rate” of binding: transcription
rate for polymerases on gene and translation rate for ribosomes on mRNAs,
k1 and k2 in the following;
— The distributions of lifetimes of mRNAs and proteins, the death rate of
mRNAs, (resp., proteins), is denoted by γ1, (resp., γ2).
DNA mRNA Protein
∅∅
k1 k2
γ1 γ2
Figure 2. Basic Chemical Reactions
(2) Determine the parameters which achieve minimal variance of concentration of a
type of protein with a fixed average concentration. When an analytical formula
for the variance is available, one can determine, in principle, the parameters that
minimize it, with the constraint of that its average is fixed. The general idea is of
determining if the current parameters of the cell are adjusted, depending of the
environment, to minimize this variance.
(3) Estimate biological parameters for experiments. Analytical formulas for the aver-
age and the variance of the number of proteins can also be used to estimate some
biological parameters. See Taniguchi [31].
The protein production process is a fundamental biological process, a process at the basis
of “life”, justifying the extensive efforts to understand and to quantify, via mathematical
models, the role of its different components: polymerases, ribosomes, mRNAs and pro-
teins. It also serves as a generic example of a typical biological process: a component of
type A is produced with components of type B, but via the creation of another component
of type C, which may also be used in the regulation of the process.
As a general remark, the mathematician should always keep in mind that she/he is
studying an incredibly complex system, the molecular biology of gene expression. It has
evolved over a time span of four billion years. A mathematical model may take into account
only partial aspects of the sophisticated mechanisms into play. In this presentation we
focus on the basic parameters of the transcription and translation phases.
Some history.
The basic principles of molecular biology, starting with Crick and Watson [36], Brenner
et al. [5] and Jacob and Monod [12], have been discovered in the 1950-1960’s. At that
time, measuring concentrations of different types of macro-molecules within the cell was
not really possible with the experimental tools available. Efficient methods to estimate
these concentrations, like the fluorescence microscopy, have been available much later
at the beginning of the 1990’s. This is probably the main motivation of mathematical
models at the end the 1970’s in the pioneering works Berg [2] and Rigney [26] to study
the fluctuations of the concentration of proteins within the cell. Analytical expressions
for the mean and the variance of the number of proteins in a cell have been derived for
some simplified models. These results were later extended in the context of Markov chain
theory. They are recalled in Section 2. The formulas obtained can give some insight on
the role of the parameters of the cell like the transcription rate of the gene or the average
lifetime of some macro-molecules on these fluctuations. Interestingly, this is one of the
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few examples in applied mathematics when mathematical models have been used before
measurements could be done. There is a huge literature on the stochastic analysis of
this process using a large range of mathematical methods. For a detailed review of these
works, see Paulsson [23]. We focus here on exact formulas that can be obtained for specific
stochastic models.
State Space of the Production Process.
In most mathematical analyses, the production process of proteins of a fixed gene is inves-
tigated. There is an implicit assumption in this case that the cell allocates a fixed fraction
of its resources to the production of the mRNAs, proteins of this gene, independently of
the production process of other proteins. With this hypotheses the production process
of this type of protein can be analyzed in isolation of the other processes within the cell.
This is a convenient given the complexity of the interactions. In this case, the produc-
tion process is usually described as a three-dimensional Markov process (I(t),M(t), P (t))
where, for t≥0,
— I(t)∈{0, 1} describes the state of the gene at time t, active or inactive;
— M(t) is the number of mRNAs at this instant;
— P (t) is the number of proteins.
For these models, the duration of elongation of mRNAs or of proteins is not taken into
account. For example, the transition M(t)→M(t)+1, the production of an mRNA, is,
implicitly, associated to the binding of a polymerase to the gene. This amounts to neglect
the elongation time of an mRNA. A glance at the numbers of Section A reveals that, in
average, the time to build an mRNA of 3000 nucleotides is 35 seconds, which is not small
compared to its lifetime, of the order of 2 minutes. Among difference types of mRNAs,
the average length is 1000, see Figure 5 of Section A in the Appendix.
Another assumption, the price of the Markov property, is that the duration of the
transitions have an exponential distribution. This hypothesis for the duration of time
to have a binding polymerase-gene or ribosome-mRNA can be justified with the current
parameters of the cell. The assumption is more questionable for lifetimes of mRNAs and,
in particular, of proteins. The lifetimes of proteins are comparable to the duration of time
between divisions of the cell. The interpretation of death/degradation is more difficult in
such a case. See the discussion on the assumptions on the distribution of lifetimes.
The Markovian description of the protein production process gives the possibility of
using classical results of Markov theory, for the convergence to equilibrium as well as for
an analytical characterization of the equilibrium points.
Numbers of copies or Concentration ?
The representation of the levels of proteins and mRNAs by numbers, i.e. integers, is conve-
nient for the mathematical analysis, in particular to investigate the stochastic fluctuations.
For some aspects, it is nevertheless more natural to express the various quantities in terms
of concentrations rather than numbers. For example, if R,M and P denotes respectively
the chemical species ribosomes, mRNAs and proteins, the production and destruction of
a protein is expressed as , using notations from chemistry,{
M+R −→ P+M+R,
P −→ ∅.
Let [A](t) denote the concentration of species A, A∈{R,M,P}, at time t≥0. This quan-
tity is the ratio of the number of macro-molecules in the cell of type A to the volume of the
cell at time t. The law of mass action of chemical physics gives the associated Michaelis-
Menten kinetics equations for the concentration of the various macro-molecules, they are
analytically expressed by a deterministic differential equation,
d
dt
[P](t) = kon[M](t)[R](t)− ν[P](t).
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See van Kampen [34] and Chapter 6 of Murray [21] for example. The parameter kon is the
rate at which a given ribosome binds to a given mRNA and ν is the exponential growth
rate of the volume of the cell. The concentration of proteins decreases mostly because of
volume growth. This is the dilution effect. In a Markovian context, see Section 2, the
number of copies of a given type of protein is used rather than its concentration. In this
case the parameter ν is interpreted as a death rate of proteins, which is less natural in
some way. In this presentation, we will nevertheless use the discrete representation with
numbers. It is more convenient to describe stochastic phenomena involving a finite, but
not too large, number of macro-molecules, like for mRNAs. See Anderson and Kurtz [1]
for an introduction on stochastic modeling of biological systems.
Organization of the Paper.
Due to its historical importance, the analysis of the first moments of the equilibrium of
Markovian models is presented in Section 2. Section 3 introduces a fundamental marked
Poisson point process used to describe the whole protein production process. It is an
extension based on the model of Fromion et al. [11]. A result of convergence to equilib-
rium is proved via a “coupling from the past” method. An important representation of
the number of mRNAs and proteins in terms of the Poisson process is established. See
Theorem 7.
In Section 4, (resp., Section 5), general formulas for the mean and variance of the
number of mRNAs (resp., of proteins), at equilibrium are established, generalizing the
classical formulas of Markovian models. An important part of the biological literature
is devoted to the analysis of these first moments, this is the main motivation of these
two sections. The results obtained are an extension, with somewhat simpler technical
arguments, of results of Fromion et al. [11]. When the gene is always active, the equilibrium
of the detailed description of the state of mRNAs is characterized by Proposition 12.
A formula for the generating function of the equilibrium distribution of the number of
proteins is established in Proposition 14. The joint distribution of the number of mRNAs
and of proteins at equilibrium is also investigated in Section 5.
In Section 6 the various approximations used in the biological literature are revisited in
the light of the results proved in the previous sections. They are formulated as new scaling
results when one of the parameters goes to infinity: switching rate of the gene, average
lifetime of proteins, translation rate, . . . generally under the constraint that the average
number of proteins is fixed. Several convergence results for the equilibrium distribution
of the number of proteins are obtained in this way. The methods rely on the results of
Section 5, probabilistic arguments and some technical estimates. A central limit theorem,
which seems to be new, is established in Proposition 18. A study on the impact of the
elongation phase of proteins on the variability of the protein production process concludes
this section. This topic is rarely addressed in mathematical models of the biological
literature. It is shown that, under some statistical assumptions, increasing the variability
of the elongation phase in a stochastic model may have the surprising effect of reducing
the variance of the equilibrium distribution of the number of proteins. A consequence
of this observation is that the choice of exponential distribution for the distribution of
the duration of the elongation phase of proteins, as it would be natural in a Markovian
context, may lead to underestimate the “real” variance.
The central result of this approach is Theorem 7, it gives an explicit representation of
the number of proteins at equilibrium in terms of a functional of a marked Poisson point
process. The main advantages are that
(1) it is not necessary to solve invariant measure equations as in the Markovian ap-
proaches;
(2) Formulas for Poisson processes, recalled in the appendix, give additional insight
on the equilibrium distribution of the number of proteins;
MATHEMATICAL MODELS OF GENE EXPRESSION 7
(3) General distributions, instead of exponential distributions, for the duration of
elongation times and lifetimes of mRNAs and proteins can be included in the
model.
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Mathematical Notations and Conventions.
Throughout this presentation, for the sake of clarity, we will frequently do the following
abuse of notations. If X is some integrable random variable on R+
(1) X(dx) will denote its distribution on R+;
(2) (Xn) an i.i.d. sequence of random variables with this distribution;
(3) FX a random variable whose distribution has density
x 7→ P(X≥x)
E(X)
,
with respect to Lebesgue’s measure on R+. We denote by (FX,n) an i.i.d. sequence
with this distribution.
Note that, with Fubini’s Theorem, for a≥0,
(1) E
(
(X−a)+) = ∫ +∞
a
P(X≥u) du = E(X)P(FX≥a),
where b+= max(b, 0), b∈R. Additionally, a simple calculation of the Laplace transform
shows that the relation FX
dist
= X holds if and only if the law of X is exponential.
Throughout the paper, we will use the following notation:
— For mRNAs, L1(dw) is the distribution of their lifetimes and E1(dv) the distri-
bution of their elongation times.
— For proteins, L2(dz) is the distribution of their lifetimes and E2(dy) the distribu-
tion of their elongation times.
The index 1 refers to mRNAs and 2 to proteins. With our convention, items (1) and (2)
above, (L1) and (E1), (resp. (L1,n) and (E1,n)), denote random variables, (resp. i.i.d.
sequences of random variables) associated to the distribution L1(dw), (resp. E1(dv)).
And similarly for proteins, for the random variables (L2) and (E2) and the i.i.d. sequences
(L2,n) and (E2,n).
2. The Classical Markovian Three-Step Model
In this section, Markovian models of the protein production process are presented.
Although these models have some limitations in terms of modeling this is an important
class of models to study the stochastic fluctuations associated to gene expression. This
is in fact the main stochastic model of gene expression used in the biological literature
from the early works of Rigney [26], Berg [2] to more recent studies Thattai and van
Oudenaarden [32], Shahrezaei and Swain [29]. See Paulsson [23] for a survey. See also
Chapter 6 of Bressloff [6] and Chapter 4 of Mackey et al. [20]. These models are still
popular in the biological literature.
A more general modeling of the stochasticity of gene expression is presented and dis-
cussed in Section 3. It is analyzed in the rest of the paper. In this section we will consider
the time evolution of the number of mRNAs and of proteins associated to a gene G0 in a
given cell (bacterium). The statistical assumptions are the following:
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ffifl
fi
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?
Figure 3. Classical Three-Step Model for Protein Production.
(1) If the gene is inactive, in state 0 say, (resp., active, in state 1), it becomes active,
(resp., inactive) after an exponentially distributed amount of time with parameter
k+ (resp., k−).
(2) If the gene is active, the mRNAs of G0 are produced according to a Poisson
process with parameter k1 and their lifetimes are exponentially distributed with
parameter γ1.
(3) during its lifetime an mRNA of G0 produces proteins according to a Poisson
process with parameter k2 and the lifetime of a protein is exponentially distributed
with parameter γ2.
For this model, the parameter k1 can be seen as the rate at which a polymerase binds on
an active gene, but also the rate at which an mRNA is produced. The steps of binding and
elongation are thus reduced to a single step. The same remark holds for the production
of proteins. The model of Section 3 distinguishes these two steps.
For t≥0, we denote I(t)∈{0, 1} the state of gene at time t and M(t)∈N, (resp., P (t)∈N),
is the number of mRNAs, (resp., of proteins), at this instant. It is easily checked that
the process (Z(t))
def
= (I(t),M(t), P (t)) is an irreducible Markov process in the state space
S0def= {0, 1}×N2. The non-zero elements of its Q-matrix Q=(q(z, z′), z, z′∈S0) outside the
diagonal are given by, for z=(i, x, y)∈S0,
q(z, z+e1)=k+1{i=0}, q(z, z−e1)=k−1{i=1},
q(z, z+e2)=k11{i=1}, q(z, z−e2)=γ1x,
q(z, z+e3)=k2x, q(z, z−e3)=γ2y,
where ei, i=1, 2, 3, are the unit vectors of S0. See Figure 3. As a functional operator Q,
it can be defined as
Q(f)(z) =
∑
z′∈S0
q(z, z′)f(z′) =
∑
z′∈S0\{z}
q(z, z′)(f(z′)−f(z)), z∈S0,
for some function f on S0. The starting point of analyses of the literature is always the
classical system of Kolmogorov’s equations associated to this Markov process
d
dt
E
[
f(Z(t))
]
= E
[
Q(f)(Z(t))
]
,
for some set of test functions f , like the indicator function of x, for x∈S0. They are
generally referred to as the master equation in this literature. Its fixed point is the invariant
distribution of the Markov process.
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Proposition 1. The Markov process (I(t),M(t), P (t)) has a unique invariant distribution
(pi(z), z∈S0) with finite second moments∑
(i,x,y)∈S0
(
x2+y2
)
pi(i, x, y) < +∞.
Proof. The proof is skipped. This result is in fact established in the next sections in a
much more general context. See the proofs of Propositions 10 and 13. 
There does not seem that there exists a closed form expression for the invariant distri-
bution (pi(i, x, y)) of the equilibrium equations. See Relation (3) below for the generating
function of P when the gene is always active. It turns out that, nevertheless, one can get
explicit expressions for the moments of this distribution. Related formulas of the kind
have been the main and essentially, the only, rigorous results of mathematical models of
gene expression starting from the first studies in 1977. They are still used in the quanti-
tative analyses of the biological literature. See the supplementary material of Taniguchi
et al. [31] for example.
Proposition 2. If (I,M, P ) is a random variable whose law is the invariant distribution
of the Markov process (I(t),M(t), P (t)), then
E(I)=δ+
def
=
k+
k++k−
, E(M)=δ+
k1
γ1
and E(P )=δ+
k1k2
γ1γ2
,
and, for the variances, if Λ=k++k−,
Var(M)
E(M)
= 1+(1−δ+) k1
Λ+γ1
(2)
Var(P )
E(P )
=1+
k2
γ1+γ2
+(1−δ+) k1k2
γ1+γ2
Λ+γ1+γ2
(Λ+γ1)(Λ+γ2)
.
The ratio of the variance and of the mean given for M and P is called the Fano factor, it
can be seen as a measure of the dispersion of the probability distribution. In the biological
literature it is interpreted as a measure of deviation from the Poisson distribution. Recall
that the Fano factor of a Poisson distribution is 1.
Proof. The proofs in the literature are generally based on the differential equations satis-
fied by the generating function of the distribution of the three-dimensional process. See
Leoncini [17]. A simple approach, avoiding manipulations of generating functions, is pre-
sented, it is based on some natural flow equations at equilibrium.
The equilibrium equations for the invariant distribution pi of the Markov process
(I(t),M(t), P (t)) can be expressed as∫
S0
Q(f)(i, x, y) dpi(i, x, y) = E[Q(f)(I,M, P )] = 0
for any function on S0 such that Q(f) is integrable with respect to pi. If, for z∈S0, by
taking f the indicator function of z, this gives the usual balance equations.
We will use the class of functions f(i, x, y)=iaxbyc, with i∈{0, 1}, a, b∈{0, 1, 2} to get
an appropriate system of linear equations to get these moments. Proposition 1 shows that
Q(f) is integrable for any function f of this class.
The equations
k+E(1−I)−k−E(I) = 0, f(i, x, y) = i,
k1E(I)−γ1E(M) = 0, f(i, x, y) = x,
k2E(M)−γ2E(P ) = 0, f(i, x, y) = y
give immediately the formulas for the first moments.
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A second system of linear equations
k1E((2M+1)I)+γ1E(M(1−2M)) = 0, f(i, x, y) = x2,
k2E(M(2P+1))+γ2E(P (1−2P )) = 0, f(i, x, y) = y2,
k1E(IP )−γ1E(MP )+k2E(M2)−γ2E(MP ) = 0, f(i, x, y) = xy,
k+E((1−I)M)−k−E(IM)+k1E(I)−γ1E(IM) = 0, f(i, x, y) = ix,
k+E((1−I)P )−k−E(IP )+k2E(IM)−γ2E(IP ) = 0, f(i, x, y) = iy,
for the variables E(M2), E(P 2), E(MP ), E(IM) and E(IP ) gives the second moments of
M and P . The proposition is proved. 
As it will be seen in a more general framework, when the gene is always active, i.e. k−=0,
the distribution of M is Poisson. This explains in particular the identity Var(M)=E(M)
of Proposition 2 in this case. See Proposition 12 of Section 4. Note that it is not the case
for P since
Var(P )
E(P )
>1,
by Proposition 2. This is usually interpreted in the biological literature as the fact that
the distribution of P is more variable than a Poisson distribution.
The above results, the first and second moments of the number of proteins at equi-
librium, are essentially the main mathematical results of the current biological literature
in this domain. As an example of application of the methods presented in this paper,
we state several results which give some additional insight on the properties of the equi-
librium distribution of the number of proteins. They are simple applications of general
results which are proved in Section 3 and 6.
An explicit representation of the generating function of P is in fact available.
Proposition 3. If the gene is always active, the generating function of the equilibrium
distribution of the number of proteins, for z∈(0, 1), is given by
(3) E
(
zP
)
= exp
(
−k1
∫
R+
[
1−e−(1−z)k2(1−e−γ2u)/γ2
]
e−γ1u du
−k1
∫
R2+
[
1−e−(1−z)k2e−γ2u(1−e−γ2w)/γ2
]
γ1e
−γ1w du dw
)
.
Bokes et al. [3] gives, via an analytic approach with the master equation, an alternative
representation of the generating function in terms of an hypergeometric function.
The classical relation (2) for the variance shows that when the gene is always active,
i.e. δ+=1, and the average lifetime 1/γ2 of proteins gets large, then
VarP
E(P )
=E
((
P − E(P )√
E(P )
)2)
∼ 1+k2
γ1
.
The following proposition gives a more precise result, when lifetimes of proteins goes to
infinity. It is a consequence of a general convergence theorem, Theorem 18 of Section 6.
Proposition 4. If the gene is always active, for the convergence in distribution, the
relation
lim
γ2→0
P−E(P )√
E(P )
= N (σ) ,
holds, where N (σ) is a centered Gaussian random variable whose standard deviation is
σ =
√
1+k2/γ1.
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This proposition gives a Gaussian approximation result for the distribution of P as
E(P )+
√
E(P )N (σ). The result should hold for protein types with a large number of
copies in the cell.
The following proposition establishes a convergence in distribution when the death rate
of mRNAs is going to infinity with the constraint that the transcription rate k2 is such
that each mRNA produces a fixed average number of proteins.
Proposition 5. If the gene is always active, then, for a>0, the relation
lim
γ1→+∞
k2/γ1=a
P = N(a),
holds for the convergence in distribution, where N(a) is random variable whose distribution
is given by, for n∈N,
P(N(a)=n) = 1
(a+1)k1/γ2
Γ(k1/γ2+n)
n! Γ(k1/γ2)
(
a
1+a
)n
.
where Γ is the classical Gamma function.
The distribution of N(a) is the negative binomial distribution with parameters k1/γ2
and a. See Chapter 5 of Johnson et al. [13]. This distribution is frequently mentioned in
the approximations of the literature, Bokes et al. [3], Friedman et al. [10] and Shahrezaei
and Swain [29] for example. It is also sometimes used to fit measurements of concentration
of proteins. Its advantage compared to a simple Poisson distribution may be due to the
fact that it is more flexible with its two parameters.
Proof. This is a straightforward application of Proposition 20 of Section 6. The elongation
time of proteins is null, i.e. E2≡0, so that the generating function of the limit N(a) is
given
E
(
zN(a)
)
= exp
(
−k1
∫ +∞
0
(1−z) ae−γ2u
1+ (1−z) ae−γ2u du
)
=
(
1
1+a−az
)κ
,
with κ=k1/γ2. Relations (37) and (38) of the appendix give the representation of this
distribution. 
3. A General Stochastic Model
We introduce in this section the stochastic processes which will be studied for the
analysis of the time evolution of the number of proteins.
The distributions of lifetimes of mRNAs and proteins are general, in particular they
are not assumed to be exponentially distributed as in the Markovian model of Section 2.
The general distributions of the duration of elongations of mRNAs and proteins are also
incorporated in the stochastic model. Once the polymerase/ribosome is bound to the
gene/mRNA, the elementary components, nucleotides for mRNAs and amino-acids for
proteins, are progressively added to build these components. As it can be seen in Figure 5
in the appendix, the number of these elements can vary from ∼20 elements up to several
thousands depending on the gene considered. This, of course, incurs delays which cannot
be really neglected. This presentation is an extension of the framework of Fromion et
al. [11]. See also Leoncini [17].
As it will be seen, a representation of the equilibrium of the protein production process
in terms of marked Poisson point processes is established.
Contrary to a Markovian analysis, the resolution of the linear system of balance equa-
tions for the equilibrium, is not necessary in this case. More general assumptions on the
distributions of some of the steps of the process can therefore be considered as mentioned
before. It should be noted however, that even in the Markovian context of the classical
three-step model, this representation simplifies much the analysis of the equilibrium. For
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example, asymptotic results concerning the equilibrium distribution of the number of pro-
teins are simpler to obtain than the approach using analytic tools with hypergeometric
functions. See Bokes et al. [3] and Section 6.2 for example.
3.1. Gene activation. The state of the gene for the type of protein is either active or
inactive. It is activated at rate k+ and inactivated at rate k−. Time duration of these
states are assumed to be exponentially distributed.
The process of activation of the gene is a Markov process (I(t), t ∈ R) with values in
{0, 1} and whose Q-matrix RI is given by rI(0, 1)=k+ and rI(1, 0)=k−. Without loss of
generality, it will be assumed to be stationary. For this reason (I(t)) is defined on the
whole real line, in some sense, the activation/inactivation process has started at t=−∞.
As it will be seen, this is a convenient formulation to describe properly the equilibrium of
the protein production process.
This process can be represented as a marked point process ((ti, Xi), i∈Z) where (ti) is
the increasing sequence of instants of change of state of the gene, with the convention that
t0≤0<t1. The marks (Xi) in the set {0, 1} indicate the state of the gene at these instants.
In particular, for i∈Z, conditionally on the event {Xi=0}, (resp., on the event {Xi=1}),
the random variable ti+1−ti is exponentially distributed with rate k+, (resp., with rate
k−). Because of our assumption on stationarity of the activation/deactivation process,
the sequence of activation instants of the gene, (ti1{Xi=1}), is a stationary renewal point
process. See Section 11.5 of Robert [27]. We denote
δ+=
k+
Λ
and Λ
def
= k++k−,
in particular P(I(t)=1)=δ+, for all t∈R.
3.2. Transcription and Translation: a Fundamental Poisson Process. When a
gene is active, a polymerase can be bound to it according to a Poisson process with rate
k1>0. The transcription phase can start. An mRNA is then being built up by a process
of aggregation of a specific sequence of nucleotides which are present in the cytoplasm.
This is the elongation phase of an mRNA. Its duration has a distribution E1(dx) on R+.
Similarly a ribosome is bound to a given mRNA according to a Poisson process with
parameter k2. The translation phase starts. A chain of amino-acids is created as the
ribosome progresses on the mRNA. This is the elongation phase of a protein. Its duration
has a distribution E2(dx) on R+. Both mRNAs and proteins have a finite lifetime. The
distribution of the lifetime of an mRNA (resp., a protein) is L1(dy) (resp., L2(dy)) on R+.
Throughout the paper, it is assumed that all these distribution have a finite first moment.
The Fundamental Poisson process. These two steps are represented by a marked
Poisson point process. See Section B of the Appendix.
(4) P def= (un, E1,n, L1,n,N2,n, n∈Z),
on the state space
S def= R×R2+×Mp(R×R2+),
where Mp(R×R2+) is the space of Radon point measures on R×R2+, see Dawson [8] for
example, and
(1) (un) is a Poisson process on R with parameter k1, this is the sequence of possible
instants when a polymerase can be bound to the gene. For n∈Z, un is indeed an
instant of binding only if the gene is active at time un. The sequence (un, n∈Z)
is assumed to be non-decreasing and indexed with the convention u0≤0<u1.
(2) (E1,n, n∈Z) is the sequence of the duration of the elongation for these mRNAs,
it is an i.i.d. sequence whose common distribution is E1.
(3) (L1,n) is the i.i.d. sequence of associated lifetimes of these mRNAs, its common
law is L1.
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Figure 4. A General Model for Protein Production.
(4) (N2,p) is an i.i.d. sequence with the same distribution as N2, a marked Poisson
point process on R×R+ with intensity k2 dx⊗E2⊗L2.
For n∈Z, N2,n=(xn2,j , En2,j , Ln2,j , j∈Z) is the process associated with the protein
production for the mRNA with index n.
(a) (xn2,j , j∈Z) is a Poisson process on R with parameter k2, this is the sequence
of possible instants when a ribosome can be bound to the mRNA with index
n. Only the instants occurring during the lifetime of this mRNA matter.
(b) (En2,j) is the sequence of the duration of the elongation of proteins by this
mRNA, it is an i.i.d. sequence whose common distribution is E2.
(c) (Ln2,j) is the i.i.d. sequence of associated lifetimes of associated proteins, its
common law is L2.
The coordinates of P(du, dv,dw,dm) are associated to the potential instants u of the
binding of a polymerase on the gene, the variable v is the elongation time of the mRNA and
the variable w is its lifetime. The last component m is the marked point process associated
to the protein production process of this mRNA. The coordinates of m(dx,dy,dz) are, x
is associated to binding instants of ribosomes on this mRNA, y is the elongation time of
the corresponding protein and z its lifetime.
The intensity measure of P is
(5) νP
def
= k1 du⊗E1⊗L1⊗Q2,
where Q2, Q2(dm)=P(N2∈ dm), is the distribution on S of the random variable N2, a
Poisson point process on R×R+ with intensity k2 dx⊗E2⊗L2.
Equivalently, if F is a non-negative Borelian function on S, then∫
S
F (u, v, w,m)νP(du, dv,dw,dm)
=
∫
S
F (u, v, w,m)k1 duE1(dv)L1(dw)Q2(dm)
=
∫
R
E(F (u,E1, L1,N2))k1 du,
where, with a slight abuse of notations, E1, L1 and N2 are independent random variables
with respective distributions E1(dv), L1(dw) and Q2(dm).
Examples. If the gene is always active and the system starts empty at time 0, the formula∑
n≥1
1{un+E1,n≤t} =
∫
R+×R2+
1{u+v≤t}P(du, dv,dw)
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gives the total number of mRNAs created up to time t. The following convention has been
used. If f is non-negative Borelian function on R×R2+,∫
S
f(u, v, w)P(du, dv,dw) =
∫
S
f(u, v, w)P(du, dv,dw,dm),
i.e. P(du, dv,dw) is the marginal distribution of P with respect to the three first coordi-
nates, i.e. it stands for P(du, dv,dw,Mp(R×R2+)).
Similarly, still with a permanently active gene,∑
n≥1
1{un+E1,n≤t<un+E1,n+L1,n} =
∫
R+×R2+
1{u+v≤t<u+v+w}P(du, dv,dw)
is the number of mRNAs present at time t≥0.
If we include the gene dynamics into the formula, the number of messengers present at
time t is∑
n≥1
I(un)1{un+E1,n≤t<un+E1,n+L1,n} =
∫
R+×R2+
I(u)1{u+v≤t<u+v+w}P(du, dv,dw)
If the mRNA with index n is created at time v=un+E2,n and if its lifetime is w then
N2,n([v, v+w)×R2+) =
∫
[v,v+w)×R+
N2,n(dx,dy,dz)
is the total number of proteins created by such an mRNA during its lifetime.
Comments on the Model
As a mathematical model, the above representation simplifies several aspects of the protein
production process but the key steps of protein production are included. Furthermore, its
main parameters have a clear biological interpretation.
(1) Expression Rates. The parameter k1 is the affinity of polymerases, or the tran-
scription rate for the gene considered. The larger this rate is, the more likely
polymerases will bind to this gene rather than to some other genes with a lower
affinity. The same remark applies for k2, the affinity of ribosomes, the translation
rate, for the corresponding mRNAs.
It should be stressed that if mRNAs and proteins are specific to a gene, poly-
merases and ribosomes are not. They can be used to create any type of mRNA
and any type protein respectively. Polymerases and ribosomes can be seen as a
kind of resources of the cell. The genes are, in some sense, competing to have
access to polymerases. This approach with the parameters k1 and k2 considers
that a specific gene receives a fixed portion of resources of the cell in terms of
polymerases and ribosomes. In particular, it does not include the competition
for access to resources between the different genes. Alternative stochastic models
have to be considered to analyze these aspects.
(2) Elongation Times. The distribution of elongation E1 of an mRNA. An mRNA is a
sequence of N nucleotides, then E1 can be represented as a sum of N independent
random variables, each of them corresponding to the duration of time required to
get each of the nucleotides within the cytoplasm. A similar situation holds for E2
for the number of amino-acids of the protein. See Figure 5 in the appendix.
(3) Lifetimes. The lifetimes of mRNAs are generally smaller than the lifetimes of
proteins, mRNAs can be indeed degraded by other RNAs in the cytoplasm after
a couple of minutes. This is one of the mechanisms used by the cell to regulate
the protein production process. The situation is quite different for proteins, their
lifetime may exceed the duration of time for cell division, of the order of 40mn
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for bacterium. At cell division, macro-molecules are assumed to be allocated at
random into one of the two daughter cells. In this case, if one follows a specific
path of cells in the associated binary tree of successive cell divisions, proteins
“vanish” simply because they have been allocated in the daughter cell. This is
referred to as the dilution phenomenon.
(4) Multiple Copies of the Gene. In a favorable environment, cells grow and divide
very quickly. In particular a copy of the DNA is always on the way in the cell,
and, therefore, another copy of the gene is present at some stage. In principle
this may double the transcription rate of the gene when the corresponding part
of the DNA has been duplicated. The rate is reduced at the division time. This
aspect has been omitted in our model, mainly for the sake of simplicity. The
main change would be that the process (I(t)) should have at least three values,
depending on the number of copies of the gene which are active at a given time.
See Paulsson [23] in a Markovian context.
The classical Markovian model of Section 2 corresponds to the case when the elongation
times of mRNAs and proteins are null and that their respective lifetimes are exponentially
distributed.
How to Handle Functionals of P.
We will use repeatedly several possible representations in the calculations of expected
values of functionals of P. We give a quick sketch of the general approach. Let f be a
non-negative Borelian function on R×R2+×R×R2+ and let, for (u, v, w,m)∈S,
F (u, v, w,m)
def
=
∫
R×R2+
f(u, v, w, x, y, z)m(dx,dy,dz).
When the gene is always active, most of random variables of interest can be expressed
under the form
X= 〈P, F 〉 def=
∫
S
F (u, v, w,m)P(du, dv,dw,dm).
As it will be seen, the variable activity of the gene adds some technical complications.
(1) Calculation of the mean. Relation (35) of the appendix gives that
E(X) =
∫
S
F (u, v, w,m)νP(du, dv,dw,dm)
=
∫
S
F (u, v, w,m)k1 duE1(dv)L1(dw)Q2(dm)=k1
∫
R
E(F (u,E1, L1,N2)) du,
with the same slight abuse of notations as before. For (u, v, w)∈R3+, since the
Poisson process N2 has intensity measure k2 dx⊗E2⊗L2 on R×R2+,
E(F (u, v, w,N2)) = E
(∫
R×R2+
f(u, v, w, x, y, z)N2(dx, dy,dz)
)
=
∫
R×R2+
f(u, v, w, x, y, z)k2 dxE2(dy)L2(dz) = k2
∫
R
E(f(u, v, w, x,E2, L2)) dx,
hence
E(X) = k1k2
∫
R2
E(f(u,E1, L1, x, E2, L2)) du dx.
For calculation of variances, the approach is similar, via Relation (36) of the
appendix and an additional trick. See the proof of Relation (13) for example.
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(2) Exponential Moments of X. For more precise results on the distribution of X,
one has to express E(exp(−ξX)), for some ξ≥0, the Laplace transform of X at ξ.
Proposition 22 of the appendix gives the relation
E
(
e−ξ〈P,F 〉
)
= exp
(
−
∫
S
(
1−e−ξF (u,v,w,m)
)
νP(du, dv,dw,dm)
)
= exp
(
−ξ
∫
S
(
1−e−ξF (u,v,w,m)
)
k1 duE1(dv)L1(dw)Q2(dm)
)
= exp
(
−k1
∫
R×R2+
(
1−E
(
e−ξF (u,v,w,N2)
))
duE1(dv)L1(dw)
)
.
By using again Proposition 22 for the Poisson process N2, with the same argu-
ments as before, we get, for (u, v, w)∈R×R2+,
E
(
e−ξF (u,v,w,N2)
)
= exp
(
−
∫
R
(
1−E
(
e−ξf(u,v,w,x,y,z)
))
k2 dxE2(dy)L2(dz)
)
= exp
(
−k2
∫
R
(
1−E
(
e−ξf(u,v,w,x,E2,L2)
))
dx
)
.
This expression for E(exp(−X)) though explicit is not simple to handle. It is
nevertheless usable to get several limit results in Section 6. The trick of using
independent random variables Ea, La, a∈{1, 2} or their distributions Ea(ds),
La(dt) is used throughout this paper. Its main advantages are of simplifying the
calculations and the expressions of the formulas obtained.
We state a simple result on some invariance properties of the Poisson process P. For
m∈Mp(R×R2+) and f is a Borelian function on R×R2+, the measure mˇ is defined by
〈mˇ, f〉=
∫
R×R2+
f(x, y, z)mˇ(dx,dy,dz) =
∫
R×R2+
f(−x, y, z)m(dx,dy,dz).
Proposition 6. If P is the marked Poisson point process on S defined by Relation (4)
and F is some non-negative Borelian function on {0, 1}×S then∫
S
F (I(u), u, v, w,m)P(du,dv,dw,dm) dist.=
∫
S
F (I(−u),−u, v, w, mˇ)P(du, dv,dw,dm)
Proof. This is a simple consequence of
— the reversibility of (I(t)). It is easily checked that (I(−t)) is a Markov process with
the same Q-matrix, and with same distribution at t=0 as (I(t)). See Kelly [15]
for example.
— If (tn) is a Poisson process on R with rate λ>0, then (−tn) is a Poisson process
with the same rate.
— The independence of (I(t)) and P.
Consequently, we have the identity
(I(un), un, L1,n,N2,n) dist= (I(−un),−un, L1,n, Nˇ2,n)
and therefore our proposition. 
3.3. Convergence to Equilibrium. As before we denote by M(t), (resp., P (t)) the
number of mRNAs, (resp., of proteins) at time t≥0. It is assumed that the initial state is
as follows: there are
— M(0) mRNAS with respective remaining lifetimes L01,k, k=1,. . . ,M(0);
— P (0) proteins with respective remaining lifetimes L02,k, k=1,. . . ,P (0). The marked
Poisson process associated to the creation of proteins by the kth mRNA present
at time 0 is denoted by N 02,k.
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For simplicity it is assumed that, initially, there are no mRNAs or proteins in their elon-
gation phase. The proof of convergence in distribution does not change if the initial state
includes components in their elongation phase.
The following theorem is the key result concerning the equilibrium distribution of the
number of mRNAs and proteins.
(1) It shows the convergence to equilibrium without having a Markovian framework
which is, usually, the classical approach to prove such a convergence. As a con-
sequence, the distribution of elongation times, lifetimes of mRNAs and proteins
can be general.
(2) The equilibrium of the number of mRNAs and of proteins are expressed in terms
of functionals of the marked Poisson process P. The closed form expressions of
averages and variances are obtained with this representation.
Theorem 7. [Number of mRNAs and Proteins at Equilibrium] As t goes to infinity, the
random variable (M(t), P (t)) converges in distribution to (M,P ) defined by
(6) M =
(∫
S
I(u)1{v≤u<v+w}P(du, dv,dw)
)
.
and
(7) P =
(∫
S
I(u)
(∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
}m(dx, dy,dz)
)
P(du, dv,dw,dm)
)
,
where P is the marked Poisson point process on S defined by Relation (4).
The proof of the convergence relies on coupling from the past arguments. The idea consists
in starting the process at time −t and to study its state at time 0, which will have the same
distribution as the original process at time t. If the process has convenient properties, of
monotonicity for example, it may happen that the state at time 0 of the shifted process
converges almost surely as t goes to infinity. This gives then the convergence in distribution
of (I(t),M(t), P (t)) when t goes to infinity. This method applies in our case. One of
the earliest works using this method seems to be Loynes [19] (1962). Its use has been
popularized later by Propp and Wilson [24] to study the Ising Model. See Levin at al. [18]
for a survey.
Proof. We first express the variables M(t) and P (t) in terms of the point process P.
The variable M(t) is the sum of the number of initial mRNAs still alive at time t and of
the number of mRNAs born before time t and still alive at time t. This gives the following
formula,
M(t) =
M(0)∑
k=1
1{
L0
2,k
>t
} +
∫
S
I(u)1{0<u+v≤t<u+v+w}P(du,dv,dw).
Similarly, P (t) is the sum of three quantities corresponding to the number of
(1) the number of proteins present at time 0 and still alive at time t,
P (0)∑
k=1
1{
L0
2,k
>t
};
(2) the number of proteins created before time t by one of the mRNAs present at
time 0 and still alive at time t,
M(0)∑
k=1
∫
R×R2+
I(u)1{
0<u<L0
1,k
,u+v≤t<u+v+w
}N 02,k(du, dv,dw);
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(3) proteins created before time t by new mRNAs and still alive at time t,
P1(t)
def
=
∫
S
I(u)1{u∈(0,t)}
(∫
R×R2+
1{u+v≤x<u+v+w
x+y≤t<x+y+z
}m(dx,dy,dz)
)
P(du, dv,dw,dm).
For simplicity of presentation, we will prove the convergence in distribution of (P (t)). The
convergence in distribution of (M(t), P (t)) is similar. Clearly, the two first terms converge
almost surely to 0 when t goes to infinity. We have thus only to take care of P1(t).
The stationarity of the process P with respect to translation by −t, Proposition 6, the
identity (I(s−t))dist= (I(s)), and the fact that (I(s)) is independent of P give that P1(t) has
the same distribution as P2(t) with
P2(t)
def
=
∫
S
I(u)1{u∈(−t,0)}
(∫
R×R2+
1{u+v≤x<u+v+w
x+y≤0<x+y+z
}m(dx, dy,dz)
)
P(du, dv,dw,dm).
The quantity P2(t) can be seen the number of proteins at time 0 when the process starts
empty at time −t, i.e. without mRNAs or proteins. This is a non-decreasing function of
t converging almost surely to P2(∞) defined by∫
S
I(u)1{u<0}
(∫
R×R2+
1{u+v≤x<u+v+w
x+y≤0<x+y+z
}m(dx, dy,dz)
)
P(du, dv,dw,dm).
Proposition 6 gives that the quantity P2(∞) has the same distribution as∫
I(u)1{u>0}
(∫
1{x+v≤u<x+v+w
y≤x<y+z
}m(dx,dy,dz)
)
P(du, dv,dw,dm).
it is easy to see that this last term is the second coordinate of (7). The theorem is
proved. 
4. Transcription
Relation (6) gives that the distribution of the number of mRNAs at equilibrium is given
by the law of the random variable M defined by
(8) M =
∫
R×R2+
I(u)G1(u, v, w)P(du, dv,dw),
with
(9) G1(u, v, w)
def
=1{v≤u<v+w}.
The process of activation/deactivation of the gene complicates significantly the deriva-
tion of the mathematical expressions for the mean and variance of M . Formulas are much
more simple when the gene is always active. We will need some technical results on this
process. We denote by FI the σ-field generated by the stochastic process (I(t)),
FI = σ 〈I(t), t∈R〉 .
A representation of the distribution of M in terms of a marked Poisson point process
conditioned on the σ-field FI is the main tool used. For the calculation of the variance
an additional work has then to be done to “remove” this conditioning. It turns out that
the correlation structure of the process (I(t)) plays a role at this stage.
Lemma 8 (Correlation Function of (I(t))). For t≥0, E(I(t))=δ+ and
P(I(t)=1|I(0)=1) = δ+ + (1−δ+)e−Λt,
where Λ=k++k− and δ+=k+/Λ.
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Proof. Let p(t)=P(I(t)=1|I(0)=1), then Kolmogorov’s forward equations give the ODE
p′(t) = k+(1−p(t))−k−p(t)
which is easily solved. 
Define PI the marked point process by, for a non-negative Borelian function on the
space Sdef=R×R2+×Mp(R×R2+),
(10)
〈
PI , f
〉
=
∫
S
I(u)f(u, v,m)P(du, dv,dm).
The following proposition gives the intuitive, but important, result that, conditionally on
FI , the point process PI is a marked Poisson point process with intensity measure
(11) νIP(du, dv,dm) = I(u)k1 duL1(dv)Q2(dm).
See Relation (5) for the unconditional case.
Proposition 9. For any non-negative Borelian function f on the state space S, the
relation
E
(
exp
(
−
〈
PI , f
〉)∣∣∣FI) = exp(−∫
S
I(u)
(
1−e−f(u,v,w,m)
)
νP (du, dv,dw,dm)
)
= exp
(
−k1
∫
S
I(u)
(
1−e−f(u,v,w,m)
)
duE1(dv)L1(dw)Q2(dm)
)
holds almost surely.
Proof. For the sake of rigor, despite of its intuitive content, a proof is given. The (formal)
difficulty is of expressing rigorously the conditioning with respect to FI . We use the
notations of Section 3.1 where the process (I(t)) is defined by the doubly infinite sequence
(ti, Xi). Denote, for N≥1,
FIN def= σ 〈(ti, Xi),−N≤i≤N〉 ,
note that, since the distribution of the finite marginals of the sequence ((ti, Xi), i∈Z)
determine its distribution, we have
lim
n→+∞
↑ FIN = FI .
Let f a non-negative Borelian function on S with compact support in the following sense:
there exists some K> 0 such that f(z)=0 if z=(u, v, w,m)∈S when u 6∈[−K,K]. On the
event {t−N≤−K, tN≥K},〈
PI , f
〉
=
N∑
i=−N
1{Xi=1}
∫
S
1{u∈[ti,ti+1)}f(u, v, w,m)P(du, dv,dw,dm).
By independence of (ti, Xi) and P and by using Proposition 22, it is easily checked that,
almost surely on this event,
E
(
exp
(
−
〈
PI , f
〉)
|FIN
)
= exp
(
−
N∑
i=−N
1{Xi=1}
∫
S
1{u∈[ti,ti+1)}
(
1−e−f(u,v,w,m)
)
νP (du, dv,dw,dm)
)
.
Indeed, one has to multiply both sides of this relation by some non-negative Borelian
function of ((ti, Xi),−N≤i≤N), take the expected value of these expressions. By using the
independence of ((ti, Xi),−N≤i≤N) and P, and the expression of the Laplace transform
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of a Poisson process, see Proposition 22, it is easy to check the equality of these two terms.
Consequently, for N sufficiently large, almost surely,
E
(
exp
(
−
〈
PI , f
〉)
|FIN
)
= exp
(
−
∫
S
I(u)
(
1−e−f(u,v,w,m)
)
νP (du, dv,dw,dm)
)
.
A classical result from martingale theory gives the almost sure convergence
lim
N→+∞
E
(
exp
(
−
〈
PI , f
〉)
|FIN
)
= E
(
exp
(
−
〈
PI , f
〉)
|FI
)
.
See Williams [38]. Hence the proposition holds for these class of functions f with compact
support in the sense defined above. We conclude with the fact that any positive Borelian
function can be expressed as a (monotone) limit of such functions. 
4.1. Mean and Variance of the Number of mRNAs at Equilibrium.
Proposition 10 (The first moments of the number of mRNAs). If M is the number of
mRNAs at equilibrium, then
(12) E(M) = k+
Λ
k1E(L1),
and
(13)
Var(M)
E(M)
= 1+E(M)k−
k+
E
(
e−Λ|FL1,1−FL1,2+E1,1−E1,2|
)
.
where Λ=k++k−, and E1,1 and E1,2 are independent random variables with distribution
E1, and FL1,1 and FL1,2 are independent random variables with density P(L1≥u)/E(L1)
on R+.
Recall that the distribution of the elongation time of an mRNA is E1 and the duration
of its life time is L1. Note that when the lifetimes L1 of an mRNA is exponentially
distributed with parameters γ1, then FL1
dist
= L1, and if the elongation time of an mRNA
is null, i.e. E1≡0, the above relation gives
Var(M)
E(M)
−1 = E(M)k−
k+
E
(
e−Λ|L1,1−L1,2|
)
=
k−
Λ
k1
γ1
E
(
e−ΛL1
)
=
k−
Λ
k1
Λ+γ1
,
since |L1,1−L1,2|dist= L1, due to the exponential assumption. This is the relation for the
variance of M in Proposition 2.
Proof. Proposition 9 gives that, almost surely,
E
(
M |FI
)
=
∫
S
I(u)1{v≤u<v+w}ν
I
P(du, dv,dw,dm)(14)
=
∫
R×R2+
I(u)1{v≤u<v+w}k1 duE1(dv)L1(dw)
= k1
∫
R
I(u)P(E1≤u<E1+L1) du,
by integrating this identity, we get from Lemma 8,
(15) E(M) = δ+
∫
R×R2+
1{v≤u<v+w}k1 duE1(dv)L1(dw) = δ+k1E(L1).
From Representation (8) of M and Relation (36) of Corollary 23, we obtain
E
(
M2|FI
)
=
(
E
(
M |FI
))2
+
∫
R×R2+
I(u)1{v≤u<v+w}k1 duE1(dv)L1(dw),
and, after integration,
(16) E
(
M2
)
= E
(
E
(
M |FI
)2)
+ E(M).
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Define
∆I(M)
def
= E
(
E(M |FI)2
)
− E(M)2,
so that Var(M)=∆I(M)+E(M). Relations (14) and (15) give
∆I(M) = E
((
E(M |FI)− E(M)
)2)
= E
[(
k1
∫
R
(I(u)−δ+)P(E1≤u<E1+L1) du
)2]
.
We can rewrite the square of the integral as a double integral in the following way,(∫
R
(I(u)−δ+)P(E1≤u<E1+L1) du
)2
=
∫
R2
(I(u)−δ+)(I(u′)−δ+)P(E1,1≤u<E1,1+L1,1)P(E1,2≤u′<E1,2+L1,2) du du′,
where the variables E1,i, i=1, 2, and L1,i, i=1, 2, are independent. The quantity ∆
I(M)
can be expressed as
∆I(M) = k1
2
∫
R2
E
[
(I(u)−δ+)(I(u′)−δ+)
]
×P(E1,1≤u<E1,1+L1, E1,2≤u′<E1,2+L1,2) du du′.
From Lemma 8 we get, for u, u′∈R+,
(17) E[(I(u)−δ+)(I(u′)−δ+)] = E(I(u)I(u′))−δ2+ = δ+(1−δ+)e−Λ|u−u
′|,
hence the quantity ∆I(M)/(k1
2δ+(1−δ+)) is given by∫
R2
e−Λ|u−u
′|P(E1,1<u<E1,1+L1,1, E1,2≤u′<E1,2+L1,2) du du′
= E
(∫
R2+
e−Λ|u+E1,1−(u
′+E1,2)|P(u≤L1,1, u′<L1,2) du du′
)
= E(L12)E
(
e−Λ|FL1,1+E1,1−(FL1,2+E1,2)|
)
.
If we gather these results into Relation (16), we obtain the identity
Var(M)
E(M)
= 1+E(M)1−δ+
δ+
E
(
e−Λ|FL1,1+E1,1−(FL1,2+E1,2)|
)
,
which is the desired formula. 
We now turn to a more detailed analysis of the invariant distribution of (M(t)) in the
case when the gene is always active.
4.2. The Equilibrium Distribution of the State of mRNAs. It is now assumed
that the process (I(t)) is constant and equal to 1. In particular δ+=1. We introduce a
random measure that describes precisely the state of the mRNAs,
Λ1(t)
def
=
M(t)∑
k=1
δRi(t) and
where Ri(t) is the residual lifetime of the ith mRNA present at time t. The measure Λ1(t)
is the empirical distribution associated to the residual lifetimes.
Proposition 11 (Convergence to Equilibrium of the number of mRNAs). When the gene
is always active, the process (Λ1(t)) converges in distribution to a random measure (Λ
∗
1)
defined by, for f a continuous function with compact support on R+,
〈Λ∗1, f〉 =
∫
S
f(v+w−u)1{v≤u<v+w}P(du, dv,dw).
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Proof. The proof is similar to the proof of Theorem 7. Theorem 3.26 of Dawson [8] is
used, it is enough to show that for the convergence in distribution
lim
t→+∞
〈Λ1(t), f〉 = 〈Λ∗1, f〉
for every non-negative continuous function f with compact support on R+. By definition
of the vector (Ri(t)),
〈Λ1(t), f〉 =
∑
n
f(un+E1,n+L1,n−t)1{0<un,un+E1,n≤t<un+E1,n+L1,n}
=
∫
S
f(u+v+w−t)1{0<u,u+v≤t<u+v+w}P(du, dv,dw)
dist
=
∫
S
f(u+v+w)1{−t<u,u+v≤0<u+v+w}P(du, dv,dw),
by invariance of the Poisson point process with respect to translation by −t, see Proposi-
tion 6. We conclude that (Λ1(t)) converges in distribution to Λ defined by
〈Λ, f〉=
∫
S
f(u+v+w)1{u+v≤0<u+v+w}P(du, dv,dw)
dist
=
∫
S
f(v+w−u)1{−u+v≤0<−u+v+w}P(du, dv,dw) = 〈Λ∗1, f〉 ,
by invariance with respect to the mapping (u, v, w) 7→(−u, v, w), again by using Proposi-
tion 6. The proposition is proved. 
This proposition states that at equilibrium the number of mRNAs is Poisson with pa-
rameter k1E(L1) and the residual lifetimes of the mRNAs are independent and distributed
as Fσ1 .
Proposition 12 (Equilibrium of the state of mRNAs). When the gene is always active,
(1) the distribution of the variable M , the number of mRNAs at equilibrium, is a
Poisson distribution with parameter E(M) given by
E(M) = k1E(L1)
(2) The residual lifetimes of the mRNAs are i.i.d. with common distribution
FL1(dx) =
P(L1>x)
E(L1)
dx.
Proof. We calculate the Laplace transform of Λ∗1, by using Proposition 22 of the appendix
and the fact that νP defined by Relation (5) is the intensity measure of the Poisson process
P, we have
E
(
e−〈Λ∗1 ,f〉
)
= exp
[
−
∫
S
(
1− e−f(v+w−u)
)
νP(du, dv,dw)
]
= exp
[
−k1
∫
S
(
1−e−f(v+w−u)
)
1{v≤u<v+w} duE1(dv)L1(dw)
]
= exp
[
−k1E(L1)
(
1−E
(
e−f(FL1 )
))]
By taking f ≡ − log(z) for some fixed z∈(0, 1), we obtain that
E
(
zM
)
= exp [−k1E(L1) (1−z)] ,
the distribution of M is Poisson with parameter E(M)=k1E(L1). Additionally, since
E
(
e−〈Λ∗1 ,f〉
)
=
+∞∑
n=0
E(M)n
n!
e−E(M)
(
E
(
e−f(FL1 )
))n
.
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we have that Λ∗1 has the same Laplace transform, and therefore the same distribution, as
the random measure
M∑
i=1
δFL1,i ,
where (FL1,i) is an i.i.d. sequence of random variables with distribution FL1 independent
of M . The proposition is proved. 
5. Translation
Theorem 7 shows that the distribution of the number of proteins at equilibrium has
the same distribution as the random variable
(18) P =
∫
S
I(u)G2(u, v, w,m)P(du, dv,dw,dm),
recall that S=R×R2+×Mp(R×R2+), and
(19) G2(u, v, w,m)
def
=
∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
}m(dx,dy,dz)
where P is the marked Poisson point process on S defined by Relation (4).
5.1. Mean and Variance of the Number of Proteins at Equilibrium.
We have an explicit representation of the variance of the number of proteins at equilibrium
given by the following proposition. This is an extension of the results of Fromion et al. [11],
see also Leoncini [17].
Proposition 13 (The two first moments of the number of proteins). If P is the number
of proteins at equilibrium, then
(20) E(P ) = k+
Λ
k1E(L1)k2E(L2),
and
(21)
Var(P )
E(P )
= 1+k2E(L2)P
(
FL1≥|E2,1−E2,2+FL2,1−FL2,2|
)
+
k−
k+
E(P )E
(
e−Λ|FL1,1−FL1,2+FL2,1−FL2,2+E1,1−E1,2+E2,1−E2,2|
)
,
where Λ=k++k− and, for a=1 and 2, the random variables Ea,1 and Ea,2, are independent
with respective distributions Ea, and FLa,1 and FLa,2 are independent random variables
with density P(La≥u)/E(La) on R+.
The proof is given in Section C of Appendix. It follows the same arguments as in the
proof of Proposition 10 but with a more technical framework due to the mark m, in the
space Mp(R×R2+), of the Poisson process P.
If the average of P does not depend on the distributions of elongation times of mRNAs
and of proteins, the second moment does depend on these distributions, and also on the
distributions of lifetimes. Note however that if Λ is large, i.e. at least one of the states of
the gene is changing rapidly, Relation (21) shows that the dependence of the distribution
of the elongation time of an mRNA on the variance is small in this case.
When the elongation times are null, i.e. E1≡0 and E2≡0 and the lifetimes L1 and
L2 are exponentially distributed with respective parameters γ1 and γ2, in this case, for
a∈{1, 2}, the variable FLa is also exponential since FLadist= La, a simple calculation gives
the classical formula (2) of the Markovian model.
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Outside the Fano parameter, the biological literature defines the noise associated to
the production of proteins as the variance of P/E(P ), the quantity Var(P )/E(P )2. The
above formulas and Relation (12) give that it can be represented as
Var(P )
E(P )2
=
1
E(P )
+
1
E(M)
P
(
FL1≥|E2,1−E2,2+FL2,1−FL2,2|
)
+
k−
k+
E
(
e−Λ|FL1,1−FL1,2+FL2,1−FL2,2+E1,1−E1,2+E2,1−E2,2|
)
.
5.2. The Equilibrium Distribution of the Number of Proteins.
When the gene is always active, an explicit expression of the generating function of P
can be obtained. As it will be seen, its form depends on the whole distribution of the
lifetimes and elongation times. Nevertheless, by using appropriate scalings, it can be used
to get limit results for its distribution and therefore some insight. This is the purpose of
Section 6.
Note that for classical Markovian models, without elongation times in particular, Re-
lation (26) of Bokes et al. [3] gives, via an analytic approach, an explicit expression of the
joint generating function of (M,P ) in terms of hypergeometric functions.
Proposition 14 (Generating Function of P ). If the gene is always active, i.e. the process
(I(t)) is constant and equal to 1, and P is the random variable defined by Relation (7),
the distribution of P is given by, for z∈[0, 1],
E
(
zP
)
= exp
(
−
∫
R2+
[
1−e−(1−z)k2E(L2)P(FL2+E2∈(u−w,u))
]
k1 duL1(dw)
)
,
where FL2 and L2 are two independent random variables and the distribution of FL2 has
density P(L2≥u)/E(L2) on R+.
Proof. Relations (18) defining P and (22) of the appendix for the Laplace transform of
Poisson point processes give
E (exp (−ξP )) = E
(
exp
(
−ξ
∫
S
G2(u, v, w,m)P(du,dv,dw,dm)
))
= exp
(
−
∫
S
[
1−e−ξG2(u,v,w,m)
]
νP(du, dv,dw,dm)
)
,
and, with Relation (5) defining νP , one has∫
S
[
1−e−ξG2(u,v,w,m)
]
νP(du,dv,dw,dm)
=
∫
S
(
1−E
(
e−ξG2(u,v,w,N2)
))
k1 duE1(dv)L1(dw),
where, as before, N2 is a Poisson process whose distribution is Q2. For (u, v, w)∈R×R2+,
(22) E
(
e−ξG2(u,v,w,N2)
)
= E
(
exp
(
−ξ
∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
}N2(dx,dy,dz)
))
= exp
(
−
(
1−e−ξ
)∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
}k2 dxE2(dy)L2(dz)
)
= exp
(
−
(
1−e−ξ
)
k2E(L2)P (FL2+E2+v≤u<FL2+E2+v+w)
)
,
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with the same arguments as in the proof of Relation (13). Hence,∫
S
[
1−e−ξG2(u,v,w,m)
]
νP(du,dv,dw,dm)
=
∫
S
[
1− exp
(
−
(
1−e−ξ
)
k2E(L2)P (u−v−w≤FL2+E2<u−v)
)]
k1 duE1(dv)L1(dw)
=
∫
S
[
1− exp
(
−
(
1−e−ξ
)
k2E(L2)P (u−w≤FL2+E2<u)
)]
k1 duL1(dw),
which gives the desired formula for the generating function. 
The explicit expression of the generating function of P for Markovian models is detailed
in Proposition 3 of Section 2.
5.3. The Joint Distribution of the Numbers of mRNAs and Proteins.
This topic is investigated in few references of the literature such as Bokes et al. [3] and
Taniguchi et al. [31]. Its motivation lies in the fact that it could be useful if some infor-
mation on the number of mRNAs could be extracted from knowledge on the number of
proteins.
We begin to study the covariance function of M and P . Relations (8) and (18) give
the representations
(23)

M =
∫
S
I(u)G1(u, v, w)P(du, dv,dw)
P =
∫
S
I(u)G2(u, v, w,m)P(du, dv,dw,dm),
where the functions G1 and G2 are defined by Relations (9) and (19). By using Proposi-
tion 9 as before on the conditional distribution of (M,P ) with respect to FI , the σ-field
associated to the state of the gene. See Section 4. Relation (36) for the covariance of
functionals of Poisson processes gives the formula
CI
def
= E
(
MP |FI
)
−E
(
M |FI
)
E
(
P |FI
)
=
∫
S
I(u)G1(u, v, w,m)G2(u, v, w,m)νP(du,dv,dw,dm).
By integrating this identity and by using the expressions of G1 and G2, we obtain that
E(CI) is equal to∫
S
E(I(u))1{v≤u<v+w}
∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
}m(dx,dy,dz)νP(du, dv,dw,dm)
= δ+k1k2E
(∫
1{0≤u<L1}
∫
R2
1{ x≤u<x+L1
E2≤x<E2+L2
} dxdu
)
= δ+k1k2E(L2)E
(
(L1−FL2 − E2)+
)
,
hence, with Relation (1),
E(CI) = E(P )P (FL1≥FL2+E2) .
Concerning the product of conditional expectations in the definition of CI , the following
identities have established in the proof of Propositions 10 and 13,
E
(
M |FI
)
= k1
∫
R
I(u)P(E1<u<E1+L1) du,
E
(
P |FI
)
= k1k2
∫
R
I(u)E
(∫
R
1{x+E1≤u<x+E1+L1
E2≤x<E2+L2
} dx
)
du.
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Using the same argument as before to express a product of integrals as a double integral,
this gives the identity
E
(
E
(
M |FI
)
E
(
P |FI
))
/(k21k2)
=
∫
R3
E
(
I(u)I(u′)
)
E
(
1{E1,1≤u<E1,1+L1,1}1{x+E1,2≤u′<x+E1,2+L1,2
E2≤x<E2+L2
}
)
dxdu′ du
By using Corollary 8 again, E[I(u)I(u′)]=δ+(δ++(1−δ+) exp(Λ|u−u′|), for u, u′≥0, the
last expression is the sum of two terms
δ2+
∫
R3
E
(
1{0≤u<L1,1}1{0≤u′<L1,2
0≤x<L2
}
)
dxdu′ du = δ2+E(L1)2E(L2)
and
δ+(1−δ+)
∫
R3
e−Λ|u−u
′|E
(
1{E1,1≤u<E1,1+L1,1}1{x+E1,2≤u′<x+E1,2+L1,2
E2≤x<E2+L2
}
)
dxdu′ du
which is, after the same manipulations as in the proof of Proposition 13,
δ+(1−δ+)E(L1)2E(L2)E
(
e−Λ|FL1,2−FL1,1+FL2+E2+E1,2−E1,1)|
)
.
We have therefore proved the following proposition.
Proposition 15 (Covariance of M and P ). If M and P are the random variables defined
by Relation (6) and (7), then the covariance of M and P is given by
(24)
Cov(M,P )
E(P )
= P (FL1≥FL2+E2) +E(M)
+
k−
k+
E(M)E
(
e−Λ|FL1,2−FL1,1+E1,2−E1,1+FL2+E2|
)
,
for E1,1 and E1,2, are independent random variables with distribution E1, and FL1,1 and
FL1,2 are independent random variables with density P(L1≥u)/E(L1) on R+, FL2 is a
random variable with density P(L1≥u)/E(L1) on R+.
The lifetime L1 of the mRNAs is usually much smaller than the lifetime L2 of proteins,
this implies that the same property also holds for the variables FL1 and FL2 . If, addition-
ally, the average number of mRNAs E(M) is small, the right-hand-side of Relation (24) is
small, so that Cov(M,P ) should be close to 0. This property has already been noticed in
some measurements, see Taniguchi et al. [31] for example. We conclude this section with
an explicit representation of the generating function of the random variable (M,P ).
Proposition 16 (Joint Distribution of M and P ). When the gene is always active,
for z1 and z2∈(0, 1),
(25) E
(
zM1 z
P
2
)
= exp
[
−k1E(L1)
∫
R+
(
1−z1 exp
[
− (1−z2) k2E(L2)P (FL2+E2≤u)
])
FL1(du)
+k1
∫
R2+
(
1− exp
[
− (1−z2) k2E(L2)P (FL2+E2∈(u, u+w))
])
duL1(dw)
]
,
where FL1 , FL2 and E2 are independent random variables and, for a∈{1, 2}, the random
variable FLa has the density P(La≥u)/E(La) on R+.
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Proof. For a1, a2>0, Relation (23) gives that
a1M+a2P =
∫
S
F (u, v, w,m)P(du,dv,dw,dm)
where
F (u, v, w,m)
def
= a1G1(u, v, w) + a2G2(u, v, w,m)
= a11{v≤u<v+w}+a2
∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
}m(dx,dy,dz).
We have, by Relation (22) of the appendix,
E
(
e−a1M−a2P
)
= exp
(
−
∫
S
(
1−e−(a1G1+a2G2)(u,v,w,m)
)
νP(du, dv,dw,dm)
)
hence
− log
(
E
(
e−a1M−a2P
))
=
∫
R×R2+
(
1−e−a1G1(u,v,w)E
(
e−a2G2(u,v,w,N2)
))
k1 duE1(dv)L1(dw).
and, if we use Relation (22),
E(
(
e−a2G2(u,v,w,N2))
)
= exp
(− (1−e−a2) k2E(L2)P (FL2+E2∈(u−v−w, u−v))) .
We conclude the proof with standard calculations. 
6. Convergence Results
The purpose of this section is of revisiting, via rigorous convergence theorems, several
classical research topics of the literature on the stochasticity of the gene expression in a
general framework concerning the distributions of lifetimes and elongation times. Most
of studies in this domain take place in the Markovian setting of Section 2 without the
elongation of mRNAs and proteins. Kolmogorov’s equations associated to the Markov
process, the “master equation” as it is usually presented, are the starting point of these
studies.
As the equilibrium equations cannot be solved explicitly, several scenarios are investi-
gated, via scalings, to get insight on the equilibrium distribution of the number of proteins:
Fast Switching rates between active and inactive states, mRNAs with short life times, pro-
teins with long lifetimes, gene with large expression rates, . . . See Friedman et al. [10], Raj
et al. [25], Shahrezaei and Swain [29], Swain et al. [30] and Thattai and van Oudenaar-
den [32]. See Bokes et al. [3] for a quite extensive analysis of the Markovian model. We will
look at three different scaling situations in the light of the results derived in the previous
sections.
(1) Long-Lived Proteins.
The distribution of lifetimes of proteins is an exponential distribution with param-
eter γ2, and its mean is converging to infinity. A central limit theorem is proved
for the equilibrium of the number P of proteins. It is shown that, in distribution,
P∼E(P )+√E(P )N , where N is a centered Gaussian random variable.
(2) Short-lived mRNAs and Long-lived Proteins.
The distribution of lifetimes of mRNAs and proteins are exponential with respec-
tive parameters γ1 and γ2, the mean lifetime 1/γ1 of mRNAs is converging to 0
and the death rate γ2 of proteins is fixed so that k1k2/(γ1γ2), the mean number
of proteins at equilibrium, is fixed.
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(3) Short-Lived mRNAs and High Expression Rate of Proteins.
The distribution of lifetimes of mRNAs and proteins are exponential with respec-
tive parameters γ1 and γ2. The mean lifetime of mRNAs is converging to 0 and
the translation rate k2 of proteins is fixed so that the quantity k2/γ1, the average
number of proteins produced by an mRNA, is fixed.
In most cases, the gene will be assumed to be always active. The reason is that, if some
results could be obtained on the distribution of P , we have not been able to get usable
expressions to get some insight in the scaling regimes analyzed here. The next result
shows that, in practice, a model with a permanently active gene is reasonable, provided
some parameters are adjusted. This is a folk result of the biological literature: if the state
of the gene switches more and more rapidly, then, in the limit, the model is equivalent to
a model with a permanently active gene but with a reduced transcription rate.
6.1. Fast Switching Rates of Gene between Active and Inactive States.
Proposition 11 shows that when the gene is always active then the equilibrium distribution
of the number of mRNAs is Poisson. This is minimal from the point of view of the
Fano factor in this class of models. If the gene switches quickly between the two states
active/inactive, one can expect an averaging effect. The following proposition establishes
this intuitive result.
Proposition 17. If PN is the random variable defined by Relation (7) with the activa-
tion/deactivation rates are respectively given by k+N and k−N for some scaling parameter
N≥1, then, for the convergence in distribution,
lim
N→+∞
PN = P,
where the distribution of P is the equilibrium distribution of the number of proteins for a
model of gene expression for which the gene is always active and with the same parameters
except for k1 which is replaced by k1k+/(k++k−).
Proof. The stationary activation/deactivation process (IN (t)) can clearly be expressed as
(I(Nt)) where (I(t)) is a stationary process with switching rates k+ and k−
Let f be an integrable function on R+ and
XN
def
=
∫
R+
I(Nu)f(u) du,
we now prove the convergence in distribution
lim
N→+∞
XN = δ+
∫
f(u) du
with δ+
def
= k+/(k++k−). Note that the convergence is certainly true for the first moment
of XN , since E(I(t))=δ+ for all t≥0.
By writing the square of XN as a double integral and with Proposition 2, we obtain
the relation
E(X2N ) = E
(∫
R2+
I(Nu)I(Nu′)f(u)f(u′) du du′
)
=
(
δ+
∫
f(u) du
)2
+ δ+(1−δ+)
∫
R2+
e−N(k++k−)|u−u
′|f(u)f(u′) du du′.
Therefore,
lim
N→+∞
E
(
(XN−E(XN ))2
)
= lim
N→+∞
E
(
X2N
)− (E(XN ))2 = 0,
in particular (XN ) converges in distribution to the limit of the sequence (E(XN )).
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Denote by FIN the filtration associated to the process (I(Nt)). Relations (18) and (19)
for PN , and (22) of the appendix for the Laplace transform of Poisson point processes give
E
(
exp (−ξPN )
∣∣∣FIN) = E(exp(−ξ ∫
S
I(Nu)G2(u, v, w,m)P(du, dv,dw,dm)
))
= exp
(
−
∫
S
I(Nu)
[
1−e−ξG2(u,v,w,m)
]
νP(du,dv,dw,dm)
)
= exp
(
−
∫
R
I(Nu)
[
1−E
(
e−ξG2(u,E1,L1,N2)
)]
k1 du
)
,
where N2 is a Poisson process whose distribution is Q2 defined by Relation (5).
By using the convergence result, we obtain that
lim
N→+∞
E (exp (−ξPN )) = exp
(
−
∫
R
[
1−E
(
e−ξG2(u,E1,L1,N2)
)]
δ+k1 du
)
,
which is the Laplace transform of the variable P associated to a Poisson process with the
same characteristics as P except that the transcription rate is δ+k1 and with the situation
that the gene is always active. 
6.2. Asymptotic Behavior of the Equilibrium Distribution.
In this section, the invariant distribution of the number of proteins when the gene is
always active is analyzed under some scaling conditions. Several of them rely on the fact
that the average lifetime of a protein is much larger than the lifetime of an mRNA, which is
of the order of 2mn for an mRNA, where, for a protein, it is at least 30mn. See the numbers
of Section A of the appendix. This approach is used in the literature to get a further
insight on the distribution of P , i.e. with more information than the first two moments
that have an explicit expression. It is usually done via approximations on the equation
satisfied by the generating function of P . See Bokes et al. [3] or Shahrezaei and Swain [29]
where this is done via an expansion of an hypergeometric function. The representation
of Proposition 14 of the generating function of P will allow to get convergence results for
the distribution of P in a quite general case and without too much technicality.
A Limiting Gaussian Distribution for the Number of Proteins
The scaling considered here assumes that the average lifetime of proteins goes to infinity
and the other parameters are fixed. In particular these proteins should be numerous within
the cell. This setting is well suited for protein types having a large number of copies, of
the order at least of 10,000 for example. The following result shows that a central limit
theorem holds in this context.
Theorem 18 (Central Limit Theorem). Under the conditions
(1) the gene is always active;
(2) the distribution L2 of lifetimes of proteins is exponential with parameter γ2;
(3) the parameters k1, k2 are fixed as well as the distribution L1 of the lifetimes of
mRNAs and the respective distributions E1 and E2 of the elongation times of
mRNAs and proteins. The distribution L1 of lifetimes of mRNAs has a finite
third moment, E(L31)<+∞,
if P is the random variable defined by Relation (7), then for the convergence in distribution,
lim
γ2→0
√
γ2 (P−E(P )) = N (σ) ,
where
σ=
√
k1E(L1)k2
(
1+k2
∫
R+
P (FL1≥|E2,1−E2,2+x|) dx
)1/2
and, for a>0, N (a) is a centered Gaussian random variable with standard deviation a.
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Despite this framework is quite natural, curiously it does not seem to have been inves-
tigated in the biological literature, even for the classical Markovian three-step model. It
gives in fact a Gaussian approximation for the number of proteins at equilibrium when the
average lifetime 1/γ2 of proteins is large. It should be noted that, in this scaling regime,
the second order does depend on the distribution of the elongation times of proteins.
Proof. By using Proposition 14, the relation FL2
dist
= L2 due to the exponential assumption
for L2, and the calculation of the proof of Relation (20) of Proposition 13, we get that,
for ξ>0,
log
[
E
(
exp
(
−√γ2ξ(P−E(P ))
))]
= −
∫
R2+
Iγ2(u,w)k1 duL1(dw),
with, for (u,w)∈R2+,
Iγ2(u,w)
def
= 1−e−(1−e−
√
γ2ξ) k2γ2 P(L2+E2∈(u−w,u))−ξ k2√
γ2
P (L2+E2∈(u−w, u)) .
The elementary inequality
(26)
∣∣∣∣1−e−x−x+x22
∣∣∣∣ ≤ x36 , for x=(1−e−ξ√γ2) k2γ2 P (L2+E2∈(u−w, u))
gives the relation
(27)
∣∣∣∣∣ Iγ2(u, v)−
(
1−e−ξ
√
γ2−ξ√γ2+1
2
ξ2γ2
)
k2
γ2
P (L2+E2∈(u−w, u))
+
1
2
ξ2γ2
k2
γ2
P (L2+E2∈(u−w, u)) +1
2
(
1−e−ξ
√
γ2
)2(k2
γ2
)2
P (L2+E2∈(u−w, u))2
∣∣∣∣∣
≤ 1
6
(
1−e−ξ
√
γ2
)3(k2
γ2
)3
P (L2+E2∈(u−w, u))3 .
After integration with respect to the measure k1 duL1(dw) on R2+ and by using the relation∣∣∣∣1−e−ξ√γ2−ξ√γ2+12ξ2γ2
∣∣∣∣ ≤ 16ξ3γ3/22 ,
we get the inequality
(28)
∣∣∣∣log [E(exp(−√γ2ξ(P−E(P ))))]−A1−A2(γ2)∣∣∣∣
≤ k1
6
(
k32B1(γ2)+k2ξ
3B2(γ2)
)
,
with
A1
def
=
1
2
k1k2ξ
2
∫
R2+
P (L2+E2∈(u−w, u)) duL1(dw),
A2(γ2)
def
=
1
2
k1
(
1−e−ξ
√
γ2
)2(k2
γ2
)2 ∫
R2+
P (L2+E2∈(u−w, u))2 duL1(dw),
B1(γ2)
def
=
(
1−e−ξ
√
γ2
)3 1
γ32
∫
R2+
P (L2+B2∈(u−w, u))3 duL1(dw),
B2(γ2)
def
=
√
γ2
∫
R2+
P (L2+E2∈(u−w, u)) duL1(dw).
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We now study the behavior of each of these four terms when γ2 goes to 0. For the first
term A1, this is is straightforward since
(29) A1 =
1
2
k1k2ξ
2
∫
R2+
P (L2+E2≤u≤L1+L2+E2) du = 1
2
k1k2ξ
2E(L1).
The second term A2(γ2) is handled in the same way as in the derivation of Relation (21)
of Proposition 13. First note that∫
R2+
P (L2+E2∈(u−w, u))2 duL1(dw) =
∫
R+
E
(
(w−|L2,1−L2,1+E2,2−L2,2|)+
)
duL1(dw)
= E(L1)P (FL1≥|L2,1−L2,1+E2,2−L2,2|)
= E(L1)
∫ +∞
0
P (FL1≥|x+E2,1−E2,2|) γ2e−γ2x dx,
with the help of the symmetry E2,1−E2,2dist= E2,2−E2,1. Note that∫ +∞
0
P (FL1≥|x+E2,1−E2,2|) dx ≤
∫ +∞
0
P (x≤FL1+|E2,1−E2,2|) dx
≤ E (FL1) +2E(E2) =
E(L21)
2E(L1)
+2E(E2)<+∞,
Lebesgue’s Theorem gives therefore the relation
(30) lim
γ2→0
A2(γ2) =
1
2
ξ2k1E(L1)k22 lim
γ2→0
∫ +∞
0
P (FL1≥|x+E2,1−E2,2|) e−γ2x dx
=
1
2
ξ2k1E(L1)k22
∫ +∞
0
P (FL1≥|x+E2,1−E2,2|) dx.
We now analyze the upper bound of Relation (28) expressed with the terms B1(γ2) and
B2(γ2). The last one is easy to handle
B2(γ2) =
√
γ2
∫
R2+
P (L2+E2∈(u−w, u)) duL1(dw) = E(L1)√γ2,
it converges to 0 as γ2 goes to 0.
For the term B1(γ2), Jensen’s Inequality and Fubini’s Theorem give∫
R2+
P (L2+E2∈(u−w, u))3 duL1(dw)=
∫
R2+
(
E
(
e−γ2(u−w−E2)
+−e−γ2(u−E2)+
))3
duL1(dw)
≤
∫
R2+
E
((
e−γ2(u−w−E2)
+−e−γ2(u−E2)+
)3)
duL1(dw)
=
∫
R2+
(
e−γ2(u−w)
+−e−γ2u
)3
duL1(dw).
With simple calculations, we get that, for w>0, the quantity∫
R+
(
e−γ2(u−w)
+−e−γ2u
)3
du
is the sum of two terms, C1 and C2, with
C1
def
=
∫ ∞
w
(
e−γ2(u−w)−e−γ2u
)3
du =
(
1−e−wγ2)3
3γ2
,
C2
def
=
∫ w
0
(
1−e−γ2u)3 du = 2e−3wγ2−9e−2wa+6wγ2+18e−wγ2−11
6γ2
.
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The elementary inequality (26) gives the relations
C1 ≤ γ22 w
3
3
and |C2| ≤ 4γ22w3.
By using the fact that L1 has a finite third moment, we deduce the relation
lim
γ2→0
(
1−e−ξ
√
γ2
)3(k2
γ2
)3 ∫
R2+
P (L2+E2∈(u−w, u))3 duL1(dw) = 0.
Relations(28), (29) and (30) give therefore the convergence
lim
γ2→0
log
[
E
(
exp(−√γ2ξ(P−E(P )))
)]
=
ξ2
2
k1k2E(L1)
(
1+k2
∫ +∞
0
P (FL1≥|x+E2,1−E2,2|) dx
)
.
The theorem is proved. 
Short-Lived mRNAs and Long-Lived Proteins
For the scaling considered in this section the death rate γ2 of proteins goes to 0 and
with the constraint that the death rate γ1 of mRNAs is such that the average number of
proteins is kept fixed and equal to a>0,
k1E(L1)k2E(L2) =
k1
γ1
k2
γ2
= a.
In particular the average lifetime 1/γ1 of an mRNA goes to 0.
Proposition 19. Under the conditions
(1) the gene is always active;
(2) the distribution of lifetimes of mRNAs and proteins are exponential with respective
parameters γ1 and γ2;
(3) the transcription and translation parameters k1 and k2>0 are fixed as well as the
distributions of the elongation times,
if P is the random variable defined by Relation (7), then for a>0, the convergence in
distribution,
lim
γ1→+∞
γ1γ2=k1k2/a
P = Pois(a),
where Pois(a) is the Poisson distribution with parameter a.
Note that Proposition 2 gives readily that
lim
γ1→+∞
γ1γ2=k1k2/a
Var(P )
E(P )
= 1.
From the point of view of the Fano factor, the fluctuations of the number of proteins are
minimal. A (rough) picture of that is that short lived mRNAs and almost permanent
proteins minimize fluctuations of gene expression. The proposition is more precise since
it states that the number of proteins at equilibrium is in fact asymptotically Poisson.
Proof. In view of Proposition 14 and, since L2 is exponentially distributed, L2
dist
= FL2 , all
we have to do is that the quantity
∆
def
=
∫
R2+
[
1− exp
(
− (1−z) k2E(L2)P
(
L2+E2∈((u−w)+, u)
))]
k1 duL1(dw)
converges to (1−z)a, as γ1 goes to infinity, with the constraint γ1γ2=k1k2/a.
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With the elementary inequality (26), we get
|∆−(1−z)k1k2∆1|≤ (1−z)
2k22
2
∆2,
with
∆1
def
=
∫
R2+
1
γ2
P
(
L2+E2∈((u−w)+, u)
)
duγ1e
−γ1w dw
and
∆2
def
=
∫
R2+
(
P
(
L2+E2∈((u−w)+, u)
)
γ2
)2
duγ1e
−γ1w dw.
We now take care of these two quantities. By invariance by translation, we have
∆1=
1
γ2
E
(∫ (
e−γ2(u−E2−w)
+−e−γ2(u−E2)+
)
duγ1e
−γ1w dw
)
=
1
γ2
E
(∫ (
e−γ2(u−w)
+ − e−γ2u
)
duγ1e
−γ1w dw
)
=
1
γ1γ2
.
The Cauchy-Shwartz Inequality gives for the second term
∆2
def
=
∫
R2+
[
1
γ2
E
((
e−γ2(u−E2−w)
+−e−γ2(u−E2)+
))]2
duγ1e
−γ1w dw
≤ E
(∫
R2+
1
γ22
(
e−γ2(u−w)
+−e−γ2u
)2
duγ1e
−γ1w dw
)
=
1
γ1γ2(γ1+γ2)
hence it converges to 0 as γ1 goes to infinity with γ1γ2 being constant. The proposition
is proved by gathering these results. 
The above result can be explained quite simply as follows. We assume that the elongation
times are null for simplicity. With the “coupling from the past” approach of Section 3.3,
if (un) denotes the non-decreasing sequence of instants of binding instants before time 0,
since the distribution of the sequence of lifetimes (L1,n) of mRNAs is converging to 0,
with high probability there should at most one protein created by the mRNA with index
n, so that
P ∼ R def=
∑
n<0
1{N2([un+E1,n,un+E1,n+L1,n])6=0,un+E1,n+L2,n>0},
and a simple calculation gives
E
(
zR
)
= exp
(
−(1− z) k2k1
γ2(γ1+k2)
)
∼ exp
(
−(1− z)k2k1
γ2γ1
)
,
as γ2 goes to 0 with γ1γ2 constant. The distribution of the variable R is asymptoti-
cally Poisson with parameter k2k1/(γ2γ1). It is not difficult to see that, with convenient
estimates, a rigorous proof could be obtained by using this observation.
Short Lived mRNAs and High Expression Rate of Proteins
In this section the death rate γ1 of proteins goes to infinity but it is assumed in addition
that the quantity k2/γ1, the average number of proteins translated by an mRNA, is
constant. In particular k2, the expression rate of proteins, is large and the average number
of proteins is fixed.
Proposition 20. Under the conditions
(1) the gene is always active;
(2) the distribution of lifetimes of mRNAs and proteins are exponential with respective
parameters γ1 and γ2;
(3) the parameters k1 and γ2>0 are fixed as well as the distributions of the elongation
times,
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if P is the random variable defined by Relation (7) , then for a>0, the relation
lim
γ1→+∞
k2/γ1=a
P = N(a),
holds for the convergence in distribution, where N(a) is a discrete random variable whose
generating function is given by, for z∈(0, 1),
E
(
zN(a)
)
= exp
−k1 ∫ +∞
0
(1−z) aE
(
e−γ2(u−E2)
+
)
1+ (1−z) aE (e−γ2(u−E2)+) du
 .
The distribution of the random variable N(a) belong to the class of generalized Neyman
Type A distributions. See Section 9 of Chapter 9 of Johnson et al. [13] for example. In the
Markovian case of Section 2, this is a negative binomial distribution. See Proposition 5.
Proof. For z∈(0, 1), the quantity − log(E(zP ))/k1 is, since FL2dist= L2,
(31) H(z)
def
=
∫
R2+
[
1−e−(1−z)k2E(L2)P(L2+E2∈(u−w,u))
]
duγ1e
−γ1w dw
=
∫
R2+
[
1−e−(1−z)k2E(L2)E
(
e−γ2(u−w/γ1−E2)
+−e−γ2(u−E2)+
)]
due−w dw.
With similar arguments as in the proof of Proposition 19 and Lebesgue’s Theorem, we
obtain the relation
lim
γ1→+∞
k2/γ1=a
H(z) =
∫
R2+
[
1−e−(1−z)aγ2E(L2)wE
(
e−γ2(u−E2)
+
)]
due−w dw.
The proposition is proved. 
6.3. The Impact of Elongation on Variability. In this section we discuss the impact
of the elongation of proteins on the variability of the protein production process. This
aspect has been rarely considered in the mathematical models of the literature. Note that
the first moments of M and P do not depend on the distributions of the elongation times.
The distribution of the random variable M and the second moment of P do not depend
on the distribution of the elongation phase of mRNAs when the gene is always active.
To simplify the presentation, we assume in this section that the lifetimes of mRNAs
and proteins are exponentially distributed with respective parameters γ1 and γ2 and that
the gene is always active.
If the protein is composed of N amino-acids, it is natural to assume that the average of
the elongation time is proportional to N , i.e. given by N/α for some α>0. An index N is
added to the variables E2 and P defined by Relation (7). Relation (21) of Proposition 13
gives that the variance of the number of proteins at equilibrium is given by,
(32) Var(PN ) =
k1k2
γ1γ2
(
1+
k2
γ2
E
(
e−γ1|SN2 +Y2|
))
by the equality in distribution FLa
dist
= La for a∈{1, 2} due to the exponential distribution
assumption, with SN2 =E
N
2,1−EN2,2 and Y2=L2,1−L2,2.
Two assumptions on the distribution of the elongation time of a protein are now con-
sidered.
(1) Markov model. The variable EN2 is an exponential random variable given by
EN2,M with
EN2,M
def
= NVα,
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where Vα is an exponential random variable with parameter α. The variable
defined by Relation (7) is denoted as PNM .
A similar assumption can be done for the elongation of mRNAs, i.e. that its
distribution is also exponential. If M0(t), (resp., P 0(t)), denotes the number of
mRNAs, (resp., proteins), being built at time t≥0, then the process
(I(t),M0(t),M(t), P 0(t), P (t))
has clearly the Markov property. This is a natural Markovian extension of the
classical Markovian model including elongation.
(2) Additive Model. The variable EN2 is given by E
N
2,A with
EN2,A
def
=
N∑
k=1
Vα,i
where (Vα,i) is an i.i.d. sequence of exponential random variables with parameter
α. This is also a natural assumption since it considers that it takes a random
amount of time with an exponential distribution to find each amino-acid of the
protein within the cytoplasm. The variable defined by Relation (7) is denoted as
PNA .
A non-intuitive phenomenon. A simple calculation gives
Var(EN2,M ) =
N2
α2
and Var(EN2,A) =
N
α2
As it can be seen the variability of the elongation time is larger for the Markov model.
Intuitively, this could suggest that the same property holds for the number of proteins,
that the variance of PNM is larger than the variance of P
N
A . But a glance at Relation (32)
suggests in fact the contrary. Indeed, the variable SN2 +Y2 will be more variable for the
Markov model and, therefore, due to this relation, the variance should be smaller. The
next proposition gives a more formal formulation of this observation. See also Leoncini [17]
for related numerical results of this kind.
Proposition 21 (Variance for a Large Number of Amino-Acids). With the above notations
for PNM and P
N
A and under the conditions
(1) the gene is always active;
(2) the distribution of lifetimes of mRNAs and proteins are exponential with respective
parameters γ1 and γ2;
(3) k1k2/(γ1γ2)=a>0,
if N is the number of amino-acids of the protein, then
E
(
PNM
)
=E
(
PNA
)
=a, and lim
N→+∞
Var
(
PNM
)
= lim
N→+∞
Var
(
PNA
)
=a,
Furthermore, if γ1<γ2, there exists a constant C>0 such that
Var(PNA )−a ≥ C
√
N
(
Var(PNM )−a
)
.
holds for all N≥1.
This proposition shows that, if the second moment of P depend on the distribution of
the elongation times, its dependence is somewhat limited for both models, Markov and
additive. It converges to some constant as the average (and the variance) of the elongation
time goes to infinity. Remember that the average number of proteins does not depend at
all on the distribution of the elongation time.
The last inequality of the proposition shows that the variance of the additive has a
much slower convergence rate to p compared with the Markov model. The condition
γ1<γ2 is just a technical condition which does not seem to be significant.
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Proof. With the notations of Relation (32), we have the elementary relations
E
(
e−γ1|SN2 |
)
≤ E
(
e−γ1|SN2 +Y2|
)
≤ E
(
e−γ1(|SN2 |−|Y2|)
)
.
Since γ1<γ2, one has
E
(
eγ1|Y2|
)
<+∞,
hence one has only to take care of the limiting behavior of E
(
exp
(−γ1|SN2 |)) as N goes
to infinity.
For the Markov model, a simple calculation gives that |SN2,M | is exponentially dis-
tributed with parameter α/N ,
E
(
e−γ1|SN2,M |
)
=
α
α+γ1N
.
For the additive model, SN2,A is a sum of N i.i.d. centered random variables
SN2,A =
N∑
k=1
(V 1α,i−V 2α,i),
where (V 1α,i) and (V
2
α,i) are i.i.d. sequences of exponential random variables with parameter
α. Let
σ
def
=
√
Var(V 1α,1−V 2α,1) =
√
2
α
and ρ
def
= E
((
V 1α,1−V 2α,1
)3)
,
Berry-Esseen’s theorem, See Feller [9] for example, gives that, for all N∈N,
(33) sup
x∈R+
∣∣∣∣∣P
(
|SN2,A|
σ
√
N
≤x
)
−P(|N (1)|≤x)
∣∣∣∣∣ ≤ 6ρσ3√N ,
where N (1) is a centered Gaussian random variable with standard deviation 1. From
Fubini’s Theorem, we have
E
(
e−γ1|SN2,A|
)
= γ1
∫ +∞
0
P
(∣∣∣SN2,A∣∣∣≤x) e−γ1x dx,
and, with the Relation (33), this gives
(34)
∣∣∣∣E(e−|SN2 |)−γ1 ∫ +∞
0
P
(
|N (1)|≤ x
σ
√
N
)
e−γ1x dx
∣∣∣∣ ≤ 6ρσ3√N .
Let aN=γ1σ
√
N , then
γ1
∫ +∞
0
P
(
|N (1)|≤ x
σ
√
N
)
e−γ1x dx = E (exp (−aN |N (1)|))
=
1
aN
√
2
pi
∫ +∞
0
e−x
2/(2a2N )e−x dx.
With Lebesgue’s Theorem, we obtain
lim
N→+∞
√
Nγ1
∫ +∞
0
P
(
|N (1)|≤ x
σ
√
N
)
e−γ1x dx =
1
γ1σ
√
2
pi
,
we conclude the proof by using Inequality (34) and Equation (32). 
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Appendix A. Some Numbers for Escherichia coli Bacterial Cells
We give some numbers and some statistics for a single cell, to give an idea of the orders
of magnitude of the different elements of this production process. It is also used to justify
some of the assumptions in the mathematical models introduced. The sources of these
numbers can be found at the address www.bioNumbers.org. The references Bremer and
Dennis [4] and Chen et al. [7] have also been used.
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Figure 5. Distributions of Sizes for Escherichia coli.
Sources of Data: Karp et al. [14] and Valgepea et al. [33].
(1) Global Parameters.
— Diameter of bacteria: ∼2·10−6m.
— Water content of a cell: 50−70%.
— Dry content of a cell: ∼55% proteins, 20% mRNAs, 10% lipids.
(2) Polymerases and Ribosomes. A ribosome is a complex macro-molecule com-
posed of ribosomal proteins, of the order of 50 units, and ribosomal RNAs cor-
responding to a total of ∼3000 nucleotides. Polymerases and ribosomes can be
seen, for the production process, as resources of the cell. They are used by all
types of genes of the cell, in some way, genes (resp., the mRNAs) of all types are
competing to have access to polymerases (resp., ribosomes) to produce mRNAs
(resp., proteins).
— Number of polymerases: 1500−11400.
— Number of ribosomes: 6800−72000.
— Rate of transcription by an RNA polymerase ∼85 nucleotides/sec.
— Rate of translation by a ribosome ∼20 amino-acids/sec.
Note that the range of variations of these numbers depends on the growth rate of
the cells, i.e. of the environment.
(3) mRNAs and Proteins.
— Number of mRNAs in a cell: ∼7800.
— Average lifetime of an mRNA: ∼2mn.
— Size of protein: ∼2·10−9m.
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— Number of proteins in a cell: ∼2.36·106.
— Diffusion coefficient of a protein: ∼10−2sec to cross cell.
Appendix B. Poisson Point Processes
The main results concerning Poisson processes used in this chapter are briefly re-
called, in the following H is a separable locally compact metric space. See Kingman [16],
Neveu [22], or Robert [27].
Definition 1. If λ>0, µ is a probability distribution on H, a marked Poisson process on
R×H with intensity λdx⊗µ is a sequence Nλ=((tn, Xn), n∈Z) of elements of R×H where
— (tn, n∈Z) is a (classical) Poisson process on R with rate λ, with the convention
that tn≤tn+1 for any n∈Z and t0≤0<t1.
— (Xn, n∈Z) is an i.i.d. sequence of random variables with values in H and whose
distribution is X(dx).
The sequence Nλ can also be seen as a marked point process on R×H, if F is a non-
negative Borelian function on R×H, then
〈Nλ, F 〉 =
∫
R×H
F (u, x)Nλ(du,dx) =
∑
n∈Z
F (tn, Xn).
The following important proposition characterizes marked Poisson point processes.
Proposition 22 (Laplace Transform of a Poisson Process). The marked point process
Nλ = (tn, Xn) is a Poisson point process with intensity λ du⊗X(dx) if and only if the
relation
E
(
exp (−〈Nλ, F 〉)
)
= exp
(
−λ
∫
R×H
(
1− e−F (s,x)
)
dsX(dx)
)
holds for any non-negative continuous function F on R×H.
Corollary 23. If F and G are non-negative functions in L2∩L1(du⊗X), then
(35) E
(∫
R×H
F (s, x)Nλ(ds, dx)
)
=
∫
R×H
F (s, x)λdsX(dx)
and
(36) Cov
(∫
R×H
F (s, x)Nλ(ds,dx),
∫
R×H
G(s, x)Nλ(ds, dx)
)
=
∫
R×H
F (s, x)G(s, x)λ dsX(dx)
Negative Binomial Distribution.
For a, b>0, let G be a random variable whose distribution has the density
ba
Γ(a)
xa−1e−bx
on R+, where Γ is the classical Gamma function
Γ(a) =
∫ +∞
0
ua−1e−u du.
See Whittaker and Watson [37] for example. Let N1 be a Poisson process on R+ with rate
1, then, for z∈[0, 1],
(37) E
(
zN ([0,G])
)
= E
(
e−G(1−z)
)
=
∫ +∞
0
ba
Γ(a)
xa−1e−(b+1−z)x dx =
(
b
1+b−z
)a
,
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additionally, for n∈N,
(38) P(N ([0, G])=n) = b
a
n!Γ(a)
∫ +∞
0
xa+n−1e−(b+1)x dx =
(
b
b+1
)a
Γ(a+n)
n!Γ(a)
1
(1+b)n
.
Appendix C. Proof of Proposition 13
As in section 4, FI denotes the σ-field generated by the stochastic process (I(t)), by using
again Proposition 9 , we have
E
(
P |FI
)
=
∫
S
G2(u, v, w,m)I(u)νP(du dv,dw,dm),
= k1
∫
S
I(u)G2(u, v, w,m) duL1(dv)Q2(dm)
= k1
∫
R
I(u)E (G2(u,E1, L1,N2)) du,
by definition of Q2, see Relation (5), and G2 is defined by Relation (18). The integration
of this identity gives
E(P ) = δ+k1E
(∫
R
∫
R×R2+
1{x+E1≤u<x+E1+L1
y≤x<y+z
}N2(dx,dy,dz) du
)
= δ+k1E
(∫
R2
1{x+E1≤u<x+E1+L1
E2≤x<E2+L2
}k2 dxdu
)
= δ+k1E(L1)k2E(L2),
where δ+=k+/Λ. The first identity of the proposition is proved.
From Representation (18) of P , Proposition 9 and Relation (36) of Corollary 23, we
obtain
E
(
P 2|FI
)
=
(
E
(
P |FI
))2
+
∫
S
I(u)G2(u, v, w,m)
2νP(du, dv,dw,dm)(39)
=
(
E
(
P |FI
))2
+ k1
∫
R
I(u)E
[
G2 (u,E1, L1,N2)2
]
du.
We now take care successively of the two terms of the right hand side of the last equality.
First we study E
[
G2 (u,E1, L1,N2)2
]
.
For u, v, w∈R+, the distribution of the random variable
G2 (u, v, w,N2) =
∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
}N2(dx,dy,dz)
is Poisson with parameter
κ(u, v, w)
def
= k2
∫
R×R2+
1{x+v≤u<x+v+w
y≤x<y+z
} dxE2(dy)L2(dz)
= k2E
(∫
R
1{x+v≤u<x+v+w
E2≤x<E2+L2
} dx
)
.
By using again Relation (36) of Corollary 23, we obtain that
k1E
(∫
R+
I(u)E
[
G2 (u,E1, L1,N2)2
]
du
)
= δ+k1
∫
R
[
E (κ(u,E1, L1)) +E
(
κ(u,E1, L1)
2)] du
= E(P ) + δ+k1
∫
R×R2+
κ(u, v, w)2 duE1(dv)L1(dw).
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For i=1, 2, as before (E2,i) and (L2,i are independent random variables with the same
distribution as E2 and L2 respectively. By rewriting κ(u, v, w)
2 as a double integral, we
obtain∫
R×R2+
κ(u, v, w)2 duE1(dv)L1(dw)
= k2
2
∫
R×R2+
E
(∫
R2
1{ x+v≤u<x+v+w
E2,1≤x<E2,1+L2,1,
x′+v≤u<x′+v+w
E2,2≤x<E2,2+L2,2
} dx dx′
)
duE1(dv)L1(dw)
= k2
2
∫
R2+
E
(∫
R2
(
w+x∧x′−x∨x′)+ 1{E2,1≤x<E2,1+L2,1
E2,2≤x′<E2,2+L2,2
} dx dx′
)
E1(dv)L1(dw),
after integration with respect to u, the translation invariance of Lebesgue’s measure on R
and Relation (1) give the relation∫
R×R2+
κ(u, v, w)2 duE1(dv)L1(dw)
= k2
2E(L1)E
(∫
R2+
P(FL1≥|E2,1+x−(E2,2+x′)|)P(L2≥x)P(L2≥x′) dxdx′
)
= E(L1)(k2E(L2))2P(FL1≥|E2,1+FL2,1−(E2,2+FL2,2)|),
hence
(40)
1
E(P )
k1
∫
R
I(u)E
[
G2 (u,E1, L1,N2)2
]
du
= 1+k2E(L2)P
(
FL1≥|E2,1+FL2,1−(E2,2+FL2,2)|
)
We now investigate the term E
(
E(P |FI)2) of Relation (39). As for the variable M of
the last section, observe that
∆I(P )
def
= E
(
E(P |FI)2
)
−E(P )2 = E
((
E(P |FI)−E(P )
)2)
= E
((
k1
∫
R
(I(u)−δ+)E (G2(u,E1, L1,N2)) du
)2)
.
We can rewrite the square of the integral as
(∫
R
(I(u)−δ+)E (G2(u,E1, L1,N2)) du
)2
=
∫
R2
(I(u)−δ+)(I(u′)−δ+)E (G2(u,E1, L1,N2))E
(
G2(u
′, E1, L1,N2)
)
du du′
=
∫
R2
(I(u)−δ+)(I(u′)−δ+)
×
∫
R2
P
(
x+E1,1≤u<x+E1,1+L1,1
E2,1≤x<E2,1+L2,1 ,
x′+E1,2≤u′<x′+E1,2+L1,2
E2,2≤x′<E2,2+L2,2
)
k2
2 dx dx′ du du′
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By using Relation (17) and the translation invariance of Lebesgue’s measure on R, we get
E
(
∆I(P )
)
= δ+(1−δ+)k12
∫
R4
e−Λ|u−u
′|
×P
(
x+E1,1≤u<x+E1,1+L1,1
E2,1≤x<E2,1+L2,1 ,
x′+E1,2≤u′<x′+E1,2+L1,2
E2,2≤x′<E2,2+L2,2
)
k2
2 dxdx′ du du′
= δ+(1−δ+)k12k22
∫
R4
e−Λ|u+x+E1,1+E2,1−(u
′+x′+E1,2+E2,2)|
P
(
0≤u<L1,1
0≤x<L2,1,
0≤u′<L1,2
0≤x′<L2,2
)
dxdx′ du du′,
which gives the identity
(41) E
(
∆I(P )
)
=
1−δ+
δ+
E(P )2
×E
(
e−Λ|FL1,1+FL2,1+E1,1+E2,1−(FL1,2+FL2,2+E1,2+E2,2)|
)
By plugging the identities (40) and (41) into Relation (39), we obtain the desired result.
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